CK1G3
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00443 | S619 | Sugiyama | PIK3C2A | SVKKLKRAVNLPRSKtADVTsLFGGEDTSRSSTRGSLNPEN |
| O14980 | S450 | Sugiyama | XPO1 CRM1 | VLVVENDQGEVVREFMKDTDsINLyKNMRETLVyLTHLDyV |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43719 | S702 | Sugiyama | HTATSF1 | EDADGKEVEDADEKLFEDDDsNEKLFDEEEDssEKLFDDsD |
| O43815 | S229 | Sugiyama | STRN | TEAEVKETAMIAKSELtDsAsVLDNFKFLEsAAADFsDEDE |
| O43815 | S301 | Sugiyama | STRN | TKEALKEFDFLVTSEEGDNEsRSAGDGTDWEKEDQCLMPEA |
| O43823 | S685 | Sugiyama | AKAP8 AKAP95 | TRVAPAPAAADAEVEQtDAEsKDAVPTE_____________ |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O60231 | S112 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | EKNRSYRLLEDsEEssEEtVsRAGsSLQKKRKKRKHLRKKR |
| O60664 | S225 | Sugiyama | PLIN3 M6PRBP1 TIP47 | PLTDAELARIAtsLDGFDVAsVQQQRQEQSyFVRLGsLSER |
| O60701 | S392 | Sugiyama | UGDH | PREQIVVDLsHPGVSEDDQVsRLVTISKDPYEACDGAHAVV |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O60841 | S66 | Sugiyama | EIF5B IF2 KIAA0741 | KEKKKQDFDEDDILKELEELsLEAQGIKADREtVAVKPTEN |
| O75581 | S1490 | PSP | LRP6 | SSSSssTKGtYFPAILNPPPsPAtERsHYTMEFGYSsNsPs |
| O75581 | T1479 | SIGNOR|PSP | LRP6 | PYDRAHVTGASSSSSssTKGtYFPAILNPPPsPAtERsHYT |
| O75581 | T1493 | SIGNOR | LRP6 | SssTKGtYFPAILNPPPsPAtERsHYTMEFGYSsNsPsTHR |
| O95218 | S153 | Sugiyama | ZRANB2 ZIS ZNF265 | KYRGKAVGPAsILKEVEDKEsEGEEEDEDEDLsKyKLDEDE |
| P04075 | S132 | Sugiyama | ALDOA ALDA | GVVPLAGtNGEtttQGLDGLsERCAQYKKDGADFAKWRCVL |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T125 | Sugiyama | ALDOA ALDA | VGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGADF |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05023 | S217 | Sugiyama | ATP1A1 | DRIPADLRIIsANGCKVDNssLtGESEPQtRsPDFtNENPL |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | S825 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PAEIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKS |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07948 | S13 | SIGNOR|PSP | LYN JTK8 | ________MGCIKSKGKDsLsDDGVDLKTQPVRNTERTIyV |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08670 | S214 | Sugiyama | VIM | LQREEAENtLQsFRQDVDNAsLARLDLERKVEsLQEEIAFL |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09972 | S132 | Sugiyama | ALDOC ALDC | GVVPLAGtDGEtttQGLDGLsERCAQYKKDGADFAKWRCVL |
| P09972 | T125 | Sugiyama | ALDOC ALDC | VGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGADF |
| P0CG47 | T55 | Sugiyama | UBB | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P0CG48 | T55 | Sugiyama | UBC | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P11047 | T943 | Sugiyama | LAMC1 LAMB2 | FYNLQSGQGCERCDCHALGstNGQCDIRTGQCECQPGITGQ |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P13010 | S318 | Sugiyama | XRCC5 G22P2 | NDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSEGK |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13637 | S207 | Sugiyama | ATP1A3 | DRVPADLRIISAHGCKVDNssLtGESEPQTRSPDCTHDNPL |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | S158 | Sugiyama | EIF2S2 EIF2B | EILEKDEALEDEDNKKDDGIsFsNQtGPAWAGSERDytyEE |
| P20648 | S228 | Sugiyama | ATP4A | DRVPADIRILAAQGCKVDNssLtGESEPQTRSPECTHESPL |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P25705 | S53 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | ARNFHASNTHLQKtGtAEMssILEERILGADtsVDLEETGR |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P25788 | Y239 | Sugiyama | PSMA3 HC8 PSC8 | ELTNGRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM____ |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30101 | S474 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yFsPANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEK |
| P30101 | S478 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | ANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKK |
| P31327 | S1021 | Sugiyama | CPS1 | RTLRQLGKKTVVVNCNPETVstDFDECDKLyFEELSLERIL |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P40925 | S326 | Sugiyama | MDH1 MDHA | NDFSREKMDLTAKELtEEKEsAFEFLssA____________ |
| P40925 | S332 | Sugiyama | MDH1 MDHA | KMDLTAKELtEEKEsAFEFLssA__________________ |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49368 | T486 | Sugiyama | CCT3 CCTG TRIC5 | LRAKHtQENCEtWGVNGEtGtLVDMKELGIWEPLAVKLQTY |
| P50993 | S215 | Sugiyama | ATP1A2 KIAA0778 | DRVPADLRIISSHGCKVDNssLtGESEPQTRSPEFTHENPL |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P53999 | S17 | Sugiyama | SUB1 PC4 RPO2TC1 | ____MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPV |
| P53999 | S19 | Sugiyama | SUB1 PC4 RPO2TC1 | __MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPVKK |
| P54577 | S386 | Sugiyama | YARS1 YARS | sRLDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGL |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62979 | T55 | Sugiyama | RPS27A UBA80 UBCEP1 | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P62987 | T55 | Sugiyama | UBA52 UBCEP2 | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63151 | S409 | Sugiyama | PPP2R2A | RTVLKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKEN |
| P63151 | S412 | Sugiyama | PPP2R2A | LKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKENIIA |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q00610 | S1494 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EEDyQALRTsIDAyDNFDNIsLAQRLEKHELIEFRRIAAYL |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q02952 | S1256 | Sugiyama | AKAP12 AKAP250 | QSKMEDtLEHTDKEVsVEtVsILsKTEGtQEADQyADEKTK |
| Q02952 | S1259 | Sugiyama | AKAP12 AKAP250 | MEDtLEHTDKEVsVEtVsILsKTEGtQEADQyADEKTKDVP |
| Q04760 | S114 | Sugiyama | GLO1 | SRKATLELTHNWGtEDDEtQsyHNGNsDPRGFGHIGIAVPD |
| Q07021 | S205 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | DCHyPEDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYT |
| Q07157 | S1065 | Sugiyama | TJP1 ZO1 | YVEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVP |
| Q12888 | S301 | Sugiyama | TP53BP1 | AQELMEsGLQIQKsPEPEVLstQEDLFDQsNKtVssDGCst |
| Q12906 | S190 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | HLTSPVVREEMEKVLAGEtLsVNDPPDVLDRQKCLAALASL |
| Q12906 | T188 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | TIHLTSPVVREEMEKVLAGEtLsVNDPPDVLDRQKCLAALA |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13435 | S317 | Sugiyama | SF3B2 SAP145 | ETDARssLGQsAsEtEEDtVsVsKKEKNRKRRNRKKKKKPQ |
| Q13541 | S112 | Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q14151 | S194 | Sugiyama | SAFB2 KIAA0138 | PAQPPEHAVDGEGFKNtLEtssLNFKVtPDIEEsLLEPENE |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14566 | S268 | Sugiyama | MCM6 | LIVVPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRALG |
| Q14566 | S271 | Sugiyama | MCM6 | VPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRALGVRD |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q53EL6 | S78 | Sugiyama | PDCD4 H731 | KAKRRLRKNssRDsGRGDsVsDsGsDALRSGLtVPtsPKGR |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q5JSH3 | S199 | Sugiyama | WDR44 RPH11 | EAVEVKGGGDVLEPVssDsLstKDFAAVEEVAPAKPPRHLt |
| Q5UIP0 | S1693 | Sugiyama | RIF1 | NLRTRNAIKRLHKRDsFDNCsLGESSKIGIsDIssLsEKtF |
| Q66LE6 | S415 | Sugiyama | PPP2R2D KIAA1541 | RASLKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDN |
| Q66LE6 | S418 | Sugiyama | PPP2R2D KIAA1541 | LKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDNVIA |
| Q6P2E9 | S887 | Sugiyama | EDC4 HEDLS | QQRDsQDAsAEQsDHDDEVAsLAsAsGGFGTKVPAPRLPAK |
| Q6P2E9 | S890 | Sugiyama | EDC4 HEDLS | DsQDAsAEQsDHDDEVAsLAsAsGGFGTKVPAPRLPAKDWK |
| Q6P996 | S722 | Sugiyama | PDXDC1 KIAA0251 | PGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQI |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q8IWS0 | S181 | Sugiyama | PHF6 CENP-31 KIAA1823 | KSRKGRPRKTNFKGLSEDtRstssHGtDEMEsssyRDRsPH |
| Q8IWS0 | T179 | Sugiyama | PHF6 CENP-31 KIAA1823 | KKKSRKGRPRKTNFKGLSEDtRstssHGtDEMEsssyRDRs |
| Q8NBJ7 | S283 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | GsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL__ |
| Q8NBS9 | S129 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | MEDAKVYVAKVDCtAHsDVCsAQGVRGYPTLKLFKPGQEAV |
| Q8ND56 | S374 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | EDPLGPNCYYDKTKsFFDNIsCDDNRERRPtWAEERRLNAE |
| Q8WU90 | S231 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | LPPGFVLKKDKKKEEKEDEIsLEDLIERERSALGPNVTKIT |
| Q8WU90 | S351 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLsEAs |
| Q8WU90 | T348 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | sVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLs |
| Q92785 | S142 | Sugiyama | DPF2 BAF45D REQ UBID4 | LLRTDPLEKRGAPDPRVDDDsLGEFPVTNsRARKRILEPDD |
| Q92974 | S976 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | sPPHsPRDFtRMQDIPEEtEsRDGEAVASES__________ |
| Q96T58 | S96 | Sugiyama | SPEN KIAA0929 MINT SHARP | TDYNEPGTIPSAARGLDDTVsIAsRSREVSGFRGGGGGPAy |
| Q96T58 | S99 | Sugiyama | SPEN KIAA0929 MINT SHARP | NEPGTIPSAARGLDDTVsIAsRSREVSGFRGGGGGPAyGPP |
| Q99622 | S97 | Sugiyama | C12orf57 C10 | GVLKFARLVKSYEAQDPEIAsLSGKLKALFLPPMTLPPHGP |
| Q99733 | S125 | Sugiyama | NAP1L4 NAP2 | KRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKVVVTE |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BTC0 | S352 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | TADQQEAKWRPGDADGTDCTsIGtIEQKSSEDQGIKGRIEK |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9GZT8 | S193 | Sugiyama | NIF3L1 ALS2CR1 MDS015 My018 | VNytQDLDKVMSAVKGIDGVsVTsFSARTGNEEQTRINLNC |
| Q9GZT8 | S196 | Sugiyama | NIF3L1 ALS2CR1 MDS015 My018 | tQDLDKVMSAVKGIDGVsVTsFSARTGNEEQTRINLNCTQK |
| Q9H1E3 | S132 | Sugiyama | NUCKS1 NUCKS JC7 | GsEEEQEEEDEAPFQEKDsGsDEDFLMEDDDDsDyGSsKKK |
| Q9H2G2 | S446 | Sugiyama | SLK KIAA0204 STK2 | KRPKLENLPDTEDQEtVDINsVsEGKENNIMITLETNIEHN |
| Q9H501 | S77 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | GRPISHSTTEDLKRFyDLsDsDsNLsGEDSKALSQKKIKKK |
| Q9H501 | S79 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | PISHSTTEDLKRFyDLsDsDsNLsGEDSKALSQKKIKKKKT |
| Q9H501 | S82 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | HSTTEDLKRFyDLsDsDsNLsGEDSKALSQKKIKKKKTQTK |
| Q9NR30 | S466 | Sugiyama | DDX21 | ETKKEAQELSQNsAIKQDAQsLHGDIPQKQREITLKGFRNG |
| Q9P2E9 | S1122 | Sugiyama | RRBP1 KIAA1398 | APAEPSSDLASKLREAEEtQstLQAECDQYRSILAETEGML |
| Q9UHR5 | S52 | Sugiyama | SAP30BP HCNGP HTRG HTRP | GSAAEEKGGLVsDAyGEDDFsRLGGDEDGYEEEEDENsRQS |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y446 | S180 | Sugiyama | PKP3 | RPVsFHERGGVGsRADyDtLsLRsLRLGPGGLDDRysLVsE |
| Q9Y446 | S183 | Sugiyama | PKP3 | sFHERGGVGsRADyDtLsLRsLRLGPGGLDDRysLVsEQLE |
| Q9Y696 | S31 | Sugiyama | CLIC4 | KEEDKEPLIELFVKAGsDGEsIGNCPFSQRLFMILWLKGVV |
| Q9Y6I9 | S259 | Sugiyama | TEX264 ZSIG11 UNQ337/PRO536 | sAAtLsPGASsRGWDDGDtRsEHSYsESGAsGssFEELDLE |
| Q9Y6I9 | T257 | Sugiyama | TEX264 ZSIG11 UNQ337/PRO536 | EtsAAtLsPGASsRGWDDGDtRsEHSYsESGAsGssFEELD |
| Q9Y6M4 | S31 | Sugiyama | CSNK1G3 | SDDRMARPSGRSGHNTRGtGssssGVLMVGPNFRVGKKIGC |
| Q9Y6M4 | S32 | Sugiyama | CSNK1G3 | DDRMARPSGRSGHNTRGtGssssGVLMVGPNFRVGKKIGCG |
| Q9Y6M4 | S33 | Sugiyama | CSNK1G3 | DRMARPSGRSGHNTRGtGssssGVLMVGPNFRVGKKIGCGN |
| Q9Y6M4 | S34 | Sugiyama | CSNK1G3 | RMARPSGRSGHNTRGtGssssGVLMVGPNFRVGKKIGCGNF |
| Q9Y6M4 | S344 | Sugiyama | CSNK1G3 | DWIGKQLPtPVGAVQQDPALssNREAHQHRDKMQQSKNQSA |
| Q9Y6M4 | S345 | Sugiyama | CSNK1G3 | WIGKQLPtPVGAVQQDPALssNREAHQHRDKMQQSKNQSAD |
| Q9Y6M4 | S372 | Sugiyama | CSNK1G3 | HRDKMQQSKNQSADHRAAWDsQQANPHHLRAHLAADRHGGS |
| Q9Y6M4 | T29 | Sugiyama | CSNK1G3 | DKSDDRMARPSGRSGHNTRGtGssssGVLMVGPNFRVGKKI |
| Q9Y6M4 | T332 | Sugiyama | CSNK1G3 | FDRKGYMFDyEyDWIGKQLPtPVGAVQQDPALssNREAHQH |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 3.170635e-09 | 8.499 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.246701e-08 | 7.904 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.442138e-08 | 7.463 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.220140e-08 | 7.141 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.500339e-07 | 6.824 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.342273e-06 | 5.630 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.755448e-06 | 5.560 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.788758e-06 | 5.422 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.114105e-05 | 4.953 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.161865e-05 | 4.935 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.519021e-05 | 4.818 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.692816e-05 | 4.771 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.099903e-05 | 4.678 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.964615e-05 | 4.528 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.687887e-05 | 4.245 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.163708e-05 | 4.210 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.458262e-05 | 4.073 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.266289e-04 | 3.897 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.351495e-04 | 3.869 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.908406e-04 | 3.719 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.402301e-04 | 3.619 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.285274e-04 | 3.483 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.503848e-04 | 3.455 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.093536e-04 | 3.388 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.199117e-04 | 3.377 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.130554e-04 | 3.384 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.093536e-04 | 3.388 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.280658e-04 | 3.368 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.488887e-04 | 3.348 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.454605e-04 | 3.351 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.545097e-04 | 3.342 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.735756e-04 | 3.325 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.111581e-04 | 3.291 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.206053e-04 | 3.283 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.535729e-04 | 3.257 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.458962e-04 | 3.190 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.333628e-04 | 3.198 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.333628e-04 | 3.198 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.230412e-04 | 3.205 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.138269e-04 | 3.146 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.614557e-04 | 3.118 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 7.989231e-04 | 3.097 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.299285e-04 | 3.081 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.034381e-03 | 2.985 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.043423e-03 | 2.982 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.009115e-03 | 2.996 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.021096e-03 | 2.991 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.992787e-04 | 3.000 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.155244e-03 | 2.937 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.239458e-03 | 2.907 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.197880e-03 | 2.922 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.248991e-03 | 2.903 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.299265e-03 | 2.886 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.299265e-03 | 2.886 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.310203e-03 | 2.883 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.432624e-03 | 2.844 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.594917e-03 | 2.797 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.594917e-03 | 2.797 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.553907e-03 | 2.809 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.601383e-03 | 2.796 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.621153e-03 | 2.790 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.757541e-03 | 2.755 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.775370e-03 | 2.751 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.998189e-03 | 2.699 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.998189e-03 | 2.699 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.998189e-03 | 2.699 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.908158e-03 | 2.719 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.097232e-03 | 2.678 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.097232e-03 | 2.678 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.099726e-03 | 2.678 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.206295e-03 | 2.656 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.448725e-03 | 2.611 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.468553e-03 | 2.608 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.446744e-03 | 2.611 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.448725e-03 | 2.611 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.723706e-03 | 2.565 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.748302e-03 | 2.561 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.748302e-03 | 2.561 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.819355e-03 | 2.550 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.875361e-03 | 2.541 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.171483e-03 | 2.499 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.265221e-03 | 2.486 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.271679e-03 | 2.485 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.286052e-03 | 2.483 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.501465e-03 | 2.456 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.677279e-03 | 2.434 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.808463e-03 | 2.419 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.646707e-03 | 2.438 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.008438e-03 | 2.397 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.008438e-03 | 2.397 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.071014e-03 | 2.390 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.111540e-03 | 2.386 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.111540e-03 | 2.386 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.111540e-03 | 2.386 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.008438e-03 | 2.397 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.111540e-03 | 2.386 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.008438e-03 | 2.397 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.188204e-03 | 2.378 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.188204e-03 | 2.378 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.188204e-03 | 2.378 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.453168e-03 | 2.351 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.618040e-03 | 2.336 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.146920e-03 | 2.288 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.073306e-03 | 2.295 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.227400e-03 | 2.282 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.227400e-03 | 2.282 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.274116e-03 | 2.278 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 5.274116e-03 | 2.278 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.427540e-03 | 2.265 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.040676e-03 | 2.219 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.040676e-03 | 2.219 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.027164e-03 | 2.220 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.675945e-03 | 2.246 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.708268e-03 | 2.243 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.675945e-03 | 2.246 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.708268e-03 | 2.243 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.116214e-03 | 2.214 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.166452e-03 | 2.210 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.530122e-03 | 2.185 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 7.731155e-03 | 2.112 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 8.474031e-03 | 2.072 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.474031e-03 | 2.072 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.571060e-03 | 2.067 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.418101e-03 | 2.075 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.774418e-03 | 2.057 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.956874e-03 | 2.048 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.022942e-03 | 2.045 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.458852e-03 | 2.024 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.673836e-03 | 2.014 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.810157e-03 | 2.008 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.887022e-03 | 2.005 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.098609e-02 | 1.959 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.098609e-02 | 1.959 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.098609e-02 | 1.959 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.098609e-02 | 1.959 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.098609e-02 | 1.959 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.098609e-02 | 1.959 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.098609e-02 | 1.959 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.098609e-02 | 1.959 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.098609e-02 | 1.959 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.098609e-02 | 1.959 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.098609e-02 | 1.959 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.069621e-02 | 1.971 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.070311e-02 | 1.970 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.087575e-02 | 1.964 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.078143e-02 | 1.967 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.187082e-02 | 1.926 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.230115e-02 | 1.910 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.232654e-02 | 1.909 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.253368e-02 | 1.902 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.380509e-02 | 1.860 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.294316e-02 | 1.888 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.294316e-02 | 1.888 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.306198e-02 | 1.884 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.266182e-02 | 1.898 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.266182e-02 | 1.898 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.317600e-02 | 1.880 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.363184e-02 | 1.865 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.391217e-02 | 1.857 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.421158e-02 | 1.847 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.517438e-02 | 1.819 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.573247e-02 | 1.803 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.642430e-02 | 1.785 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.644622e-02 | 1.784 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.737491e-02 | 1.760 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.737491e-02 | 1.760 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.746485e-02 | 1.758 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.976079e-02 | 1.704 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.988933e-02 | 1.701 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.893226e-02 | 1.723 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.906294e-02 | 1.720 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.969686e-02 | 1.706 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.812511e-02 | 1.742 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.999049e-02 | 1.699 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.071786e-02 | 1.684 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.197464e-02 | 1.658 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.197464e-02 | 1.658 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.197464e-02 | 1.658 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.197464e-02 | 1.658 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.197464e-02 | 1.658 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.197464e-02 | 1.658 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.236384e-02 | 1.650 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.236384e-02 | 1.650 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.327223e-02 | 1.633 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.331278e-02 | 1.632 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.529807e-02 | 1.597 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.538145e-02 | 1.595 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.608296e-02 | 1.584 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.529807e-02 | 1.597 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.704676e-02 | 1.568 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.538145e-02 | 1.595 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.437400e-02 | 1.613 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.667716e-02 | 1.574 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.667716e-02 | 1.574 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.428262e-02 | 1.615 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.774708e-02 | 1.557 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.793872e-02 | 1.554 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.793872e-02 | 1.554 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.818180e-02 | 1.550 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.858470e-02 | 1.544 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.919267e-02 | 1.535 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.919676e-02 | 1.535 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.992594e-02 | 1.524 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.056712e-02 | 1.515 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.120273e-02 | 1.506 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.120273e-02 | 1.506 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.146329e-02 | 1.502 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.146329e-02 | 1.502 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.146329e-02 | 1.502 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.164800e-02 | 1.500 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.326277e-02 | 1.478 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.557903e-02 | 1.449 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.584954e-02 | 1.446 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.584954e-02 | 1.446 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.595758e-02 | 1.444 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.686207e-02 | 1.433 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.737800e-02 | 1.427 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.752369e-02 | 1.426 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.752369e-02 | 1.426 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.752369e-02 | 1.426 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.752369e-02 | 1.426 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.866598e-02 | 1.413 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.932861e-02 | 1.405 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.606061e-02 | 1.337 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 4.606061e-02 | 1.337 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.565951e-02 | 1.340 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.594238e-02 | 1.338 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.565951e-02 | 1.340 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.877158e-02 | 1.312 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.877158e-02 | 1.312 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.877158e-02 | 1.312 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.877158e-02 | 1.312 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.560362e-02 | 1.255 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.560362e-02 | 1.255 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.877062e-02 | 1.312 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.922447e-02 | 1.308 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.688255e-02 | 1.245 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.688255e-02 | 1.245 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.499140e-02 | 1.260 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.499140e-02 | 1.260 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.533615e-02 | 1.257 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.119409e-02 | 1.291 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.119409e-02 | 1.291 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.877062e-02 | 1.312 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.499140e-02 | 1.260 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.580794e-02 | 1.253 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.015910e-02 | 1.300 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.877062e-02 | 1.312 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.389082e-02 | 1.268 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.087799e-02 | 1.293 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.499140e-02 | 1.260 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.560362e-02 | 1.255 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.877158e-02 | 1.312 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.688255e-02 | 1.245 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.688255e-02 | 1.245 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.887633e-02 | 1.311 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.957339e-02 | 1.305 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.619285e-02 | 1.250 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.847619e-02 | 1.314 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.822910e-02 | 1.317 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.191210e-02 | 1.285 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.560362e-02 | 1.255 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.382080e-02 | 1.269 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.957339e-02 | 1.305 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.248987e-02 | 1.280 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.922447e-02 | 1.308 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.877062e-02 | 1.312 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.748518e-02 | 1.240 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.892449e-02 | 1.230 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.902629e-02 | 1.229 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.023801e-02 | 1.220 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.152282e-02 | 1.211 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.167425e-02 | 1.210 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.167425e-02 | 1.210 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.167425e-02 | 1.210 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.167425e-02 | 1.210 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.292496e-02 | 1.201 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.341961e-02 | 1.198 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.341961e-02 | 1.198 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.341961e-02 | 1.198 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.341961e-02 | 1.198 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.341961e-02 | 1.198 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.397376e-02 | 1.194 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.401850e-02 | 1.194 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.434623e-02 | 1.191 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.523883e-02 | 1.185 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.523883e-02 | 1.185 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.570167e-02 | 1.182 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.590349e-02 | 1.181 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.333661e-02 | 1.079 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 8.333661e-02 | 1.079 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 8.333661e-02 | 1.079 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 8.333661e-02 | 1.079 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 8.333661e-02 | 1.079 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.619317e-02 | 1.118 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.619317e-02 | 1.118 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.669787e-02 | 1.176 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.429831e-02 | 1.129 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.310334e-02 | 1.080 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.310334e-02 | 1.080 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.624034e-02 | 1.118 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.890873e-02 | 1.162 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.519332e-02 | 1.124 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.707366e-02 | 1.173 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.875867e-02 | 1.104 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.910879e-02 | 1.102 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.893137e-02 | 1.103 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.521599e-02 | 1.124 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.519332e-02 | 1.124 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.619317e-02 | 1.118 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.469729e-02 | 1.127 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.875867e-02 | 1.104 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.268532e-02 | 1.083 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.799698e-02 | 1.168 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.799698e-02 | 1.168 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.875867e-02 | 1.104 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.875867e-02 | 1.104 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.136280e-02 | 1.090 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.959255e-02 | 1.157 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.519332e-02 | 1.124 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.333661e-02 | 1.079 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.669787e-02 | 1.176 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.995666e-02 | 1.155 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.691353e-02 | 1.174 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.835508e-02 | 1.106 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.258281e-02 | 1.083 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.131388e-02 | 1.147 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.406088e-02 | 1.075 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.785394e-02 | 1.056 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.785394e-02 | 1.056 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.984734e-02 | 1.046 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.053696e-02 | 1.043 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.053696e-02 | 1.043 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.200591e-02 | 1.036 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 9.226361e-02 | 1.035 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 9.227980e-02 | 1.035 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 9.227980e-02 | 1.035 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.452145e-02 | 1.024 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.498430e-02 | 1.022 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.641714e-02 | 1.016 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.718907e-02 | 1.012 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.718907e-02 | 1.012 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.753341e-02 | 1.011 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.883384e-02 | 1.005 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.883384e-02 | 1.005 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.010441e-01 | 0.995 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.010441e-01 | 0.995 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.010441e-01 | 0.995 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.044297e-01 | 0.981 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.048737e-01 | 0.979 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.048775e-01 | 0.979 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.051210e-01 | 0.978 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.055610e-01 | 0.976 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.055610e-01 | 0.976 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.055610e-01 | 0.976 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 1.055610e-01 | 0.976 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.056701e-01 | 0.976 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.056701e-01 | 0.976 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.067067e-01 | 0.972 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.068170e-01 | 0.971 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.068170e-01 | 0.971 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.068170e-01 | 0.971 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.068170e-01 | 0.971 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.068170e-01 | 0.971 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.068170e-01 | 0.971 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.068170e-01 | 0.971 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.077907e-01 | 0.967 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.077985e-01 | 0.967 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.083183e-01 | 0.965 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.097989e-01 | 0.959 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.097989e-01 | 0.959 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.103741e-01 | 0.957 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.104310e-01 | 0.957 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.104310e-01 | 0.957 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.480922e-01 | 0.829 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.480922e-01 | 0.829 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.480922e-01 | 0.829 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.480922e-01 | 0.829 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.480922e-01 | 0.829 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.480922e-01 | 0.829 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.480922e-01 | 0.829 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.298138e-01 | 0.887 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.286947e-01 | 0.890 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.286947e-01 | 0.890 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.221646e-01 | 0.913 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.385967e-01 | 0.858 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.424294e-01 | 0.846 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.299690e-01 | 0.886 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.210146e-01 | 0.917 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.306364e-01 | 0.884 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.286947e-01 | 0.890 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.384911e-01 | 0.859 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.298138e-01 | 0.887 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.170405e-01 | 0.932 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.140517e-01 | 0.943 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.186160e-01 | 0.926 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 1.424294e-01 | 0.846 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.186160e-01 | 0.926 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.224860e-01 | 0.912 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.395728e-01 | 0.855 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.472706e-01 | 0.832 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.480922e-01 | 0.829 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.286947e-01 | 0.890 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.383180e-01 | 0.859 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.173152e-01 | 0.931 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.182941e-01 | 0.927 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.435698e-01 | 0.843 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.186160e-01 | 0.926 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.189496e-01 | 0.925 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.284358e-01 | 0.891 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.484618e-01 | 0.828 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.490456e-01 | 0.827 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.528123e-01 | 0.816 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.558024e-01 | 0.807 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.558024e-01 | 0.807 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.558024e-01 | 0.807 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.558024e-01 | 0.807 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.559382e-01 | 0.807 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.559382e-01 | 0.807 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.559382e-01 | 0.807 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.567387e-01 | 0.805 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.567903e-01 | 0.805 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.570246e-01 | 0.804 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.577244e-01 | 0.802 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.581906e-01 | 0.801 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.581906e-01 | 0.801 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.598475e-01 | 0.796 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.600253e-01 | 0.796 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.615629e-01 | 0.792 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.637851e-01 | 0.786 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.656563e-01 | 0.781 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.682086e-01 | 0.774 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.700861e-01 | 0.769 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.700861e-01 | 0.769 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.700861e-01 | 0.769 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.700861e-01 | 0.769 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.700861e-01 | 0.769 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.700861e-01 | 0.769 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.700861e-01 | 0.769 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.734006e-01 | 0.761 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.022298e-01 | 0.694 | 0 | 0 |
| TWIK-related spinal cord K+ channel (TRESK) | R-HSA-1299344 | 2.022298e-01 | 0.694 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.022298e-01 | 0.694 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.022298e-01 | 0.694 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.874552e-01 | 0.541 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.874552e-01 | 0.541 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.874552e-01 | 0.541 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 2.874552e-01 | 0.541 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 2.874552e-01 | 0.541 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.874552e-01 | 0.541 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.874552e-01 | 0.541 | 0 | 0 |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | R-HSA-5619035 | 2.874552e-01 | 0.541 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.874552e-01 | 0.541 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.878605e-01 | 0.726 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.878605e-01 | 0.726 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.878605e-01 | 0.726 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 2.288566e-01 | 0.640 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.288566e-01 | 0.640 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.288566e-01 | 0.640 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.288566e-01 | 0.640 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.635805e-01 | 0.439 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.635805e-01 | 0.439 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.635805e-01 | 0.439 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.635805e-01 | 0.439 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.635805e-01 | 0.439 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.635805e-01 | 0.439 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.635805e-01 | 0.439 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.832313e-01 | 0.737 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.832313e-01 | 0.737 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.703651e-01 | 0.568 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.703651e-01 | 0.568 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 2.703651e-01 | 0.568 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.923194e-01 | 0.716 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.923194e-01 | 0.716 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.412629e-01 | 0.618 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.412629e-01 | 0.618 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.412629e-01 | 0.618 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.118090e-01 | 0.506 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.118090e-01 | 0.506 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.118090e-01 | 0.506 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.315769e-01 | 0.365 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.315769e-01 | 0.365 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.315769e-01 | 0.365 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.315769e-01 | 0.365 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.315769e-01 | 0.365 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.153950e-01 | 0.667 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.153950e-01 | 0.667 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.713263e-01 | 0.567 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.713263e-01 | 0.567 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.713263e-01 | 0.567 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.713263e-01 | 0.567 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.391743e-01 | 0.621 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.391743e-01 | 0.621 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.391743e-01 | 0.621 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.527287e-01 | 0.453 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.527287e-01 | 0.453 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.527287e-01 | 0.453 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.527287e-01 | 0.453 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.527287e-01 | 0.453 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.527287e-01 | 0.453 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.903031e-01 | 0.721 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.903031e-01 | 0.721 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.017583e-01 | 0.520 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.017583e-01 | 0.520 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.635197e-01 | 0.579 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.074861e-01 | 0.683 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.859072e-01 | 0.731 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.859072e-01 | 0.731 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.536352e-01 | 0.596 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.536352e-01 | 0.596 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.882973e-01 | 0.540 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.323372e-01 | 0.478 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.323372e-01 | 0.478 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.323372e-01 | 0.478 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 3.323372e-01 | 0.478 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.927635e-01 | 0.406 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.927635e-01 | 0.406 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.927635e-01 | 0.406 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.923120e-01 | 0.308 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.923120e-01 | 0.308 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.923120e-01 | 0.308 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.923120e-01 | 0.308 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.747985e-01 | 0.561 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.878246e-01 | 0.726 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.133778e-01 | 0.504 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.133778e-01 | 0.504 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.133778e-01 | 0.504 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.133778e-01 | 0.504 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 3.628633e-01 | 0.440 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.386381e-01 | 0.470 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.316355e-01 | 0.365 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.316355e-01 | 0.365 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.316355e-01 | 0.365 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.180784e-01 | 0.497 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.180784e-01 | 0.497 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.931586e-01 | 0.405 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.931586e-01 | 0.405 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.931586e-01 | 0.405 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.841152e-01 | 0.547 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.841152e-01 | 0.547 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.696671e-01 | 0.569 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.639620e-01 | 0.439 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.195789e-01 | 0.495 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.457129e-01 | 0.610 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.193685e-01 | 0.496 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.193685e-01 | 0.496 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.193685e-01 | 0.496 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.892413e-01 | 0.410 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 4.230665e-01 | 0.374 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 4.230665e-01 | 0.374 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.691365e-01 | 0.329 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.691365e-01 | 0.329 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.181606e-01 | 0.497 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.841810e-01 | 0.415 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.841810e-01 | 0.415 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.553058e-01 | 0.449 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.818829e-01 | 0.550 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.317613e-01 | 0.479 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.524514e-01 | 0.344 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.524514e-01 | 0.344 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.090205e-01 | 0.510 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.986577e-01 | 0.399 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 4.392743e-01 | 0.357 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.051155e-01 | 0.297 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.051155e-01 | 0.297 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.051155e-01 | 0.297 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.051155e-01 | 0.297 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.051155e-01 | 0.297 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.051155e-01 | 0.297 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.051155e-01 | 0.297 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.915889e-01 | 0.407 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.184673e-01 | 0.378 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.018144e-01 | 0.396 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.638535e-01 | 0.334 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.381938e-01 | 0.358 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.381938e-01 | 0.358 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.381938e-01 | 0.358 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.381938e-01 | 0.358 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.278966e-01 | 0.369 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.355020e-01 | 0.361 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.355020e-01 | 0.361 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.715098e-01 | 0.327 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.092074e-01 | 0.293 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.522713e-01 | 0.345 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.689534e-01 | 0.329 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.620935e-01 | 0.335 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.469396e-01 | 0.350 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.961491e-01 | 0.528 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.808869e-01 | 0.551 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.216904e-01 | 0.283 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.499555e-01 | 0.347 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.686877e-01 | 0.571 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.087324e-01 | 0.389 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.920985e-01 | 0.716 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.786983e-01 | 0.422 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.008757e-01 | 0.697 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.639620e-01 | 0.439 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.373905e-01 | 0.625 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.536352e-01 | 0.596 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.786466e-01 | 0.320 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.339883e-01 | 0.363 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.713263e-01 | 0.567 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.051155e-01 | 0.297 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.278966e-01 | 0.369 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.945844e-01 | 0.711 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.927635e-01 | 0.406 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.061384e-01 | 0.296 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.230665e-01 | 0.374 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.051155e-01 | 0.297 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.386381e-01 | 0.470 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.180784e-01 | 0.497 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 4.524514e-01 | 0.344 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.432360e-01 | 0.464 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.194490e-01 | 0.284 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.311195e-01 | 0.636 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.981011e-01 | 0.526 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.418403e-01 | 0.355 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.527287e-01 | 0.453 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.316355e-01 | 0.365 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.316355e-01 | 0.365 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.689534e-01 | 0.329 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.817574e-01 | 0.317 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.260722e-01 | 0.371 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.230665e-01 | 0.374 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.811975e-01 | 0.318 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.878605e-01 | 0.726 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.391743e-01 | 0.621 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.927635e-01 | 0.406 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.316355e-01 | 0.365 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.691365e-01 | 0.329 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.811975e-01 | 0.318 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.459651e-01 | 0.351 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.535625e-01 | 0.452 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.118666e-01 | 0.291 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.931586e-01 | 0.405 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.931586e-01 | 0.405 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.117660e-01 | 0.291 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.715098e-01 | 0.327 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.412629e-01 | 0.618 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.713263e-01 | 0.567 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.074861e-01 | 0.683 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.923120e-01 | 0.308 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.499555e-01 | 0.347 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.880393e-01 | 0.312 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.706465e-01 | 0.431 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.944760e-01 | 0.404 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.412629e-01 | 0.618 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.807114e-01 | 0.318 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.247372e-01 | 0.648 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.761688e-01 | 0.425 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.323682e-01 | 0.364 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.247372e-01 | 0.648 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.796766e-01 | 0.746 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.981011e-01 | 0.526 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.527216e-01 | 0.597 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 2.874552e-01 | 0.541 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.878605e-01 | 0.726 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.878605e-01 | 0.726 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.153950e-01 | 0.667 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.635197e-01 | 0.579 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.230665e-01 | 0.374 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.691365e-01 | 0.329 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 4.143759e-01 | 0.383 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.286160e-01 | 0.483 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.316720e-01 | 0.479 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.927874e-01 | 0.307 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.166346e-01 | 0.380 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.043409e-01 | 0.517 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.175574e-01 | 0.286 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.063584e-01 | 0.685 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.887395e-01 | 0.311 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.017265e-01 | 0.695 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.235605e-01 | 0.651 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.963071e-01 | 0.528 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.392200e-01 | 0.470 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.343499e-01 | 0.362 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.323372e-01 | 0.478 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.628633e-01 | 0.440 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.808869e-01 | 0.551 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.856112e-01 | 0.544 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.260722e-01 | 0.371 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.855213e-01 | 0.314 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.323682e-01 | 0.364 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.343499e-01 | 0.362 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.691570e-01 | 0.329 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.168790e-01 | 0.287 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.691570e-01 | 0.329 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.882973e-01 | 0.540 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.808869e-01 | 0.551 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.715040e-01 | 0.566 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.019499e-01 | 0.299 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.019499e-01 | 0.299 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.019499e-01 | 0.299 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.019499e-01 | 0.299 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.162968e-01 | 0.287 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.001002e-01 | 0.699 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.927635e-01 | 0.406 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.927635e-01 | 0.406 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.195789e-01 | 0.495 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.163916e-01 | 0.380 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.882973e-01 | 0.540 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.759031e-01 | 0.559 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.235224e-01 | 0.490 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.823601e-01 | 0.418 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.022298e-01 | 0.694 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.874552e-01 | 0.541 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.635805e-01 | 0.439 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.923194e-01 | 0.716 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.118090e-01 | 0.506 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.315769e-01 | 0.365 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 4.315769e-01 | 0.365 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.017583e-01 | 0.520 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.927635e-01 | 0.406 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.927635e-01 | 0.406 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.668531e-01 | 0.574 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.195789e-01 | 0.495 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.716407e-01 | 0.566 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.691365e-01 | 0.329 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.691365e-01 | 0.329 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.981011e-01 | 0.526 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.062317e-01 | 0.391 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.951315e-01 | 0.403 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.054906e-01 | 0.687 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.889330e-01 | 0.311 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.907508e-01 | 0.720 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.251929e-01 | 0.647 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.485755e-01 | 0.458 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.741178e-01 | 0.759 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.017870e-01 | 0.520 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.230665e-01 | 0.374 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.915889e-01 | 0.407 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.516059e-01 | 0.454 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.516059e-01 | 0.454 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.516059e-01 | 0.454 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.844541e-01 | 0.546 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.943097e-01 | 0.404 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.010715e-01 | 0.521 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.422206e-01 | 0.466 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.589827e-01 | 0.445 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.288566e-01 | 0.640 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 3.323372e-01 | 0.478 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.927635e-01 | 0.406 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.923120e-01 | 0.308 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.628633e-01 | 0.440 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.986577e-01 | 0.399 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.330185e-01 | 0.633 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.117660e-01 | 0.291 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.800988e-01 | 0.319 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.927874e-01 | 0.307 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.531067e-01 | 0.452 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.355020e-01 | 0.361 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.903031e-01 | 0.721 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.380596e-01 | 0.358 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.381938e-01 | 0.358 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.138406e-01 | 0.289 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.055326e-01 | 0.296 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.619513e-01 | 0.582 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.524514e-01 | 0.344 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.544074e-01 | 0.594 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.892413e-01 | 0.410 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.553058e-01 | 0.449 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.253535e-01 | 0.488 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.997818e-01 | 0.523 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.235605e-01 | 0.651 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.874552e-01 | 0.541 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.288566e-01 | 0.640 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.635805e-01 | 0.439 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.703651e-01 | 0.568 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.017583e-01 | 0.520 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.074861e-01 | 0.683 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.923120e-01 | 0.308 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.923120e-01 | 0.308 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.923120e-01 | 0.308 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 3.133778e-01 | 0.504 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.628633e-01 | 0.440 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.691365e-01 | 0.329 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.691365e-01 | 0.329 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.253535e-01 | 0.488 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.051155e-01 | 0.297 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.715098e-01 | 0.327 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.016348e-01 | 0.521 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.019499e-01 | 0.299 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.097590e-01 | 0.387 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.118090e-01 | 0.506 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.527287e-01 | 0.453 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.392200e-01 | 0.470 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.691365e-01 | 0.329 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.940280e-01 | 0.712 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.117660e-01 | 0.291 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.143759e-01 | 0.383 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.499555e-01 | 0.347 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.118090e-01 | 0.506 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.527287e-01 | 0.453 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.527287e-01 | 0.453 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.923120e-01 | 0.308 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.316355e-01 | 0.365 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.971262e-01 | 0.705 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.499555e-01 | 0.347 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.986577e-01 | 0.399 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.931586e-01 | 0.405 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.552141e-01 | 0.450 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.747985e-01 | 0.561 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.963071e-01 | 0.528 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.586083e-01 | 0.445 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.153950e-01 | 0.667 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.927635e-01 | 0.406 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.118090e-01 | 0.506 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.527287e-01 | 0.453 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.323372e-01 | 0.478 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.927635e-01 | 0.406 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.691365e-01 | 0.329 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.855213e-01 | 0.314 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.316355e-01 | 0.365 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.316355e-01 | 0.365 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.931586e-01 | 0.405 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.355020e-01 | 0.361 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.691365e-01 | 0.329 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.818829e-01 | 0.550 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.141237e-01 | 0.503 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.565670e-01 | 0.448 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.204879e-01 | 0.657 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.117660e-01 | 0.291 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.531067e-01 | 0.452 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.882973e-01 | 0.540 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.316355e-01 | 0.365 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.316355e-01 | 0.365 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.051155e-01 | 0.297 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.143759e-01 | 0.383 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.216904e-01 | 0.283 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.332444e-01 | 0.273 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.340967e-01 | 0.272 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.340967e-01 | 0.272 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.342943e-01 | 0.272 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.343263e-01 | 0.272 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.343263e-01 | 0.272 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.343263e-01 | 0.272 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.343263e-01 | 0.272 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.343263e-01 | 0.272 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.349761e-01 | 0.272 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.349761e-01 | 0.272 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.349761e-01 | 0.272 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.364010e-01 | 0.271 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.364010e-01 | 0.271 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.394699e-01 | 0.268 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.394699e-01 | 0.268 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.394699e-01 | 0.268 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.394699e-01 | 0.268 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.394699e-01 | 0.268 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.394699e-01 | 0.268 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.394699e-01 | 0.268 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.394699e-01 | 0.268 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.394699e-01 | 0.268 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.394699e-01 | 0.268 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.465608e-01 | 0.262 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.465608e-01 | 0.262 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.465608e-01 | 0.262 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.465608e-01 | 0.262 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.465608e-01 | 0.262 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.465608e-01 | 0.262 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.465608e-01 | 0.262 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.465608e-01 | 0.262 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.465608e-01 | 0.262 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.465608e-01 | 0.262 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.465608e-01 | 0.262 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.465608e-01 | 0.262 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.491050e-01 | 0.260 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.524753e-01 | 0.258 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.524753e-01 | 0.258 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.524753e-01 | 0.258 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.524753e-01 | 0.258 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.576199e-01 | 0.254 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.576199e-01 | 0.254 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.597995e-01 | 0.252 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.602202e-01 | 0.252 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.605333e-01 | 0.251 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.627140e-01 | 0.250 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.627140e-01 | 0.250 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.627140e-01 | 0.250 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.631133e-01 | 0.249 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.705150e-01 | 0.244 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.705150e-01 | 0.244 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.721361e-01 | 0.243 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.721361e-01 | 0.243 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.754062e-01 | 0.240 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.769411e-01 | 0.239 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.796556e-01 | 0.237 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.796556e-01 | 0.237 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.796556e-01 | 0.237 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.828091e-01 | 0.234 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.866573e-01 | 0.232 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.880965e-01 | 0.231 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.880965e-01 | 0.231 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.880965e-01 | 0.231 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 5.880965e-01 | 0.231 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.926692e-01 | 0.227 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.931672e-01 | 0.227 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.950157e-01 | 0.225 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.950157e-01 | 0.225 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.950157e-01 | 0.225 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.950157e-01 | 0.225 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.950157e-01 | 0.225 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.950157e-01 | 0.225 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.950157e-01 | 0.225 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.950157e-01 | 0.225 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.950157e-01 | 0.225 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.950157e-01 | 0.225 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.950157e-01 | 0.225 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.950157e-01 | 0.225 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.950157e-01 | 0.225 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.950157e-01 | 0.225 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.950157e-01 | 0.225 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.950157e-01 | 0.225 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.950157e-01 | 0.225 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.950157e-01 | 0.225 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.970020e-01 | 0.224 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.003507e-01 | 0.222 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.010483e-01 | 0.221 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.010483e-01 | 0.221 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.012909e-01 | 0.221 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.030824e-01 | 0.220 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.030824e-01 | 0.220 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.030824e-01 | 0.220 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.030824e-01 | 0.220 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.054816e-01 | 0.218 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.078136e-01 | 0.216 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.111731e-01 | 0.214 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.112204e-01 | 0.214 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.121969e-01 | 0.213 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.125114e-01 | 0.213 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.125114e-01 | 0.213 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.125114e-01 | 0.213 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.157709e-01 | 0.211 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.211048e-01 | 0.207 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.217698e-01 | 0.206 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.305525e-01 | 0.200 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.305525e-01 | 0.200 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.323036e-01 | 0.199 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.323036e-01 | 0.199 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.323036e-01 | 0.199 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.323036e-01 | 0.199 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.323036e-01 | 0.199 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.323036e-01 | 0.199 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.323036e-01 | 0.199 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.337862e-01 | 0.198 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.359334e-01 | 0.197 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.359334e-01 | 0.197 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.359334e-01 | 0.197 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.359334e-01 | 0.197 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.370548e-01 | 0.196 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.382953e-01 | 0.195 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.382953e-01 | 0.195 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.382953e-01 | 0.195 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.382953e-01 | 0.195 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.382953e-01 | 0.195 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.382953e-01 | 0.195 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.382953e-01 | 0.195 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.382953e-01 | 0.195 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.382953e-01 | 0.195 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.382953e-01 | 0.195 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.382953e-01 | 0.195 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.482792e-01 | 0.188 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.540333e-01 | 0.184 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.583475e-01 | 0.182 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.598148e-01 | 0.181 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.598148e-01 | 0.181 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.598148e-01 | 0.181 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 6.598148e-01 | 0.181 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.598148e-01 | 0.181 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.598148e-01 | 0.181 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.598148e-01 | 0.181 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.611177e-01 | 0.180 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.611177e-01 | 0.180 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.654587e-01 | 0.177 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.672088e-01 | 0.176 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.676748e-01 | 0.175 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.676748e-01 | 0.175 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.704442e-01 | 0.174 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.756824e-01 | 0.170 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.769519e-01 | 0.169 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.769519e-01 | 0.169 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.769519e-01 | 0.169 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.769519e-01 | 0.169 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.769519e-01 | 0.169 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.769519e-01 | 0.169 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.769519e-01 | 0.169 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.769519e-01 | 0.169 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.769519e-01 | 0.169 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.769519e-01 | 0.169 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.769519e-01 | 0.169 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.769519e-01 | 0.169 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.769519e-01 | 0.169 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.769519e-01 | 0.169 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.769519e-01 | 0.169 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.769519e-01 | 0.169 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.797171e-01 | 0.168 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.797171e-01 | 0.168 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.797171e-01 | 0.168 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.797171e-01 | 0.168 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 6.797171e-01 | 0.168 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.797474e-01 | 0.168 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.797474e-01 | 0.168 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 6.797474e-01 | 0.168 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.855716e-01 | 0.164 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.855716e-01 | 0.164 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.856478e-01 | 0.164 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.856478e-01 | 0.164 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.856478e-01 | 0.164 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.875339e-01 | 0.163 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.001352e-01 | 0.155 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.001352e-01 | 0.155 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.001352e-01 | 0.155 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.001352e-01 | 0.155 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.001352e-01 | 0.155 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.001352e-01 | 0.155 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.002367e-01 | 0.155 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.002367e-01 | 0.155 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.031798e-01 | 0.153 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.066012e-01 | 0.151 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.074233e-01 | 0.150 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.098469e-01 | 0.149 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.098469e-01 | 0.149 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.114792e-01 | 0.148 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.114792e-01 | 0.148 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.114792e-01 | 0.148 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.114792e-01 | 0.148 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.114792e-01 | 0.148 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.114792e-01 | 0.148 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.114792e-01 | 0.148 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.114792e-01 | 0.148 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.114792e-01 | 0.148 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.114792e-01 | 0.148 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.141395e-01 | 0.146 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.147363e-01 | 0.146 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.162831e-01 | 0.145 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.195193e-01 | 0.143 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.195193e-01 | 0.143 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.251745e-01 | 0.140 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.275312e-01 | 0.138 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.281627e-01 | 0.138 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.285436e-01 | 0.138 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.285436e-01 | 0.138 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.285436e-01 | 0.138 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.308367e-01 | 0.136 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.311565e-01 | 0.136 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.311565e-01 | 0.136 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.324663e-01 | 0.135 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.324663e-01 | 0.135 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.324663e-01 | 0.135 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.324663e-01 | 0.135 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.324663e-01 | 0.135 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.324663e-01 | 0.135 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 7.324663e-01 | 0.135 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.324663e-01 | 0.135 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.324663e-01 | 0.135 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.324663e-01 | 0.135 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.324663e-01 | 0.135 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.379142e-01 | 0.132 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.379142e-01 | 0.132 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.423180e-01 | 0.129 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.423180e-01 | 0.129 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.423180e-01 | 0.129 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.423180e-01 | 0.129 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.423180e-01 | 0.129 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.423180e-01 | 0.129 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.423180e-01 | 0.129 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.423180e-01 | 0.129 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.423180e-01 | 0.129 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.423180e-01 | 0.129 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.423180e-01 | 0.129 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.423180e-01 | 0.129 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.428913e-01 | 0.129 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.484182e-01 | 0.126 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.535672e-01 | 0.123 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.535672e-01 | 0.123 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.535672e-01 | 0.123 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.535672e-01 | 0.123 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.535672e-01 | 0.123 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.535672e-01 | 0.123 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.535672e-01 | 0.123 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.535672e-01 | 0.123 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.536320e-01 | 0.123 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.553391e-01 | 0.122 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.553391e-01 | 0.122 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.597446e-01 | 0.119 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.618463e-01 | 0.118 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.618463e-01 | 0.118 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.665256e-01 | 0.115 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.673677e-01 | 0.115 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.678896e-01 | 0.115 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.698622e-01 | 0.114 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.698622e-01 | 0.114 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.698622e-01 | 0.114 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.698622e-01 | 0.114 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.698622e-01 | 0.114 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.698622e-01 | 0.114 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.698622e-01 | 0.114 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.698622e-01 | 0.114 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.698622e-01 | 0.114 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.718173e-01 | 0.112 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.718173e-01 | 0.112 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.732156e-01 | 0.112 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.732156e-01 | 0.112 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.732156e-01 | 0.112 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.732156e-01 | 0.112 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.751111e-01 | 0.111 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.753115e-01 | 0.111 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.753115e-01 | 0.111 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.753115e-01 | 0.111 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.761091e-01 | 0.110 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.761091e-01 | 0.110 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.761358e-01 | 0.110 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.761358e-01 | 0.110 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.761358e-01 | 0.110 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.783801e-01 | 0.109 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.799634e-01 | 0.108 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.825563e-01 | 0.106 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.847642e-01 | 0.105 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.853401e-01 | 0.105 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.868672e-01 | 0.104 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.873754e-01 | 0.104 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.914810e-01 | 0.102 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.914810e-01 | 0.102 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.914810e-01 | 0.102 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.914810e-01 | 0.102 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.914810e-01 | 0.102 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.914810e-01 | 0.102 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.914810e-01 | 0.102 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.914810e-01 | 0.102 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.924000e-01 | 0.101 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.944636e-01 | 0.100 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.944636e-01 | 0.100 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.944636e-01 | 0.100 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.944636e-01 | 0.100 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.944636e-01 | 0.100 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.944636e-01 | 0.100 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.944636e-01 | 0.100 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.944636e-01 | 0.100 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.944636e-01 | 0.100 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.944636e-01 | 0.100 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.944636e-01 | 0.100 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.944636e-01 | 0.100 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.944636e-01 | 0.100 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.944636e-01 | 0.100 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.946748e-01 | 0.100 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.946748e-01 | 0.100 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.995326e-01 | 0.097 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.007168e-01 | 0.097 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.020426e-01 | 0.096 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.062571e-01 | 0.094 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.062571e-01 | 0.094 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.062571e-01 | 0.094 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.062571e-01 | 0.094 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.084344e-01 | 0.092 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.084344e-01 | 0.092 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.164365e-01 | 0.088 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 8.164365e-01 | 0.088 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.164365e-01 | 0.088 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 8.164365e-01 | 0.088 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 8.164365e-01 | 0.088 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.164365e-01 | 0.088 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.164365e-01 | 0.088 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.164365e-01 | 0.088 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.173142e-01 | 0.088 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.173142e-01 | 0.088 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.204261e-01 | 0.086 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.206429e-01 | 0.086 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.241476e-01 | 0.084 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.241476e-01 | 0.084 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.241476e-01 | 0.084 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.241476e-01 | 0.084 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.241476e-01 | 0.084 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.241476e-01 | 0.084 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.241476e-01 | 0.084 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.252519e-01 | 0.083 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.260300e-01 | 0.083 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.265979e-01 | 0.083 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.288309e-01 | 0.082 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.308967e-01 | 0.080 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.311855e-01 | 0.080 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.325803e-01 | 0.080 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.331664e-01 | 0.079 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.334834e-01 | 0.079 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.360614e-01 | 0.078 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.360614e-01 | 0.078 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.360614e-01 | 0.078 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.360614e-01 | 0.078 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.360614e-01 | 0.078 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.360614e-01 | 0.078 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.360614e-01 | 0.078 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.360614e-01 | 0.078 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.360614e-01 | 0.078 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.360614e-01 | 0.078 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.360614e-01 | 0.078 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.360614e-01 | 0.078 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.360614e-01 | 0.078 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.360614e-01 | 0.078 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.360614e-01 | 0.078 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.360614e-01 | 0.078 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.360614e-01 | 0.078 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.376286e-01 | 0.077 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.379029e-01 | 0.077 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.379029e-01 | 0.077 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.379029e-01 | 0.077 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.386918e-01 | 0.076 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.386918e-01 | 0.076 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.386918e-01 | 0.076 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.386918e-01 | 0.076 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.410186e-01 | 0.075 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.410186e-01 | 0.075 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.410186e-01 | 0.075 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.418577e-01 | 0.075 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.418577e-01 | 0.075 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.474613e-01 | 0.072 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.474613e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.480650e-01 | 0.072 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.503371e-01 | 0.070 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.515110e-01 | 0.070 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.521374e-01 | 0.069 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.521374e-01 | 0.069 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.521374e-01 | 0.069 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.521374e-01 | 0.069 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.524475e-01 | 0.069 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.535893e-01 | 0.069 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.535893e-01 | 0.069 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.535893e-01 | 0.069 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.535893e-01 | 0.069 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.535893e-01 | 0.069 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.535893e-01 | 0.069 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.535893e-01 | 0.069 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.535893e-01 | 0.069 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.535893e-01 | 0.069 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.535893e-01 | 0.069 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.548031e-01 | 0.068 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.573006e-01 | 0.067 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.584919e-01 | 0.066 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.611495e-01 | 0.065 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.617517e-01 | 0.065 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.631526e-01 | 0.064 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.631526e-01 | 0.064 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.645530e-01 | 0.063 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.645530e-01 | 0.063 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.645530e-01 | 0.063 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.645530e-01 | 0.063 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.672404e-01 | 0.062 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.692441e-01 | 0.061 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.692441e-01 | 0.061 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.692441e-01 | 0.061 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.692441e-01 | 0.061 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.692441e-01 | 0.061 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.692441e-01 | 0.061 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.692441e-01 | 0.061 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.692441e-01 | 0.061 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.731683e-01 | 0.059 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.748723e-01 | 0.058 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.760051e-01 | 0.057 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 8.760051e-01 | 0.057 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.760051e-01 | 0.057 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.760228e-01 | 0.057 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.809487e-01 | 0.055 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.811301e-01 | 0.055 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.825292e-01 | 0.054 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.832258e-01 | 0.054 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.832258e-01 | 0.054 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.832258e-01 | 0.054 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.832258e-01 | 0.054 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.832258e-01 | 0.054 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.832258e-01 | 0.054 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.832258e-01 | 0.054 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.832258e-01 | 0.054 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.832258e-01 | 0.054 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.832258e-01 | 0.054 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.832258e-01 | 0.054 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.836870e-01 | 0.054 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.842978e-01 | 0.053 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.842978e-01 | 0.053 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.865577e-01 | 0.052 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.865577e-01 | 0.052 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.865577e-01 | 0.052 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.865577e-01 | 0.052 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.912692e-01 | 0.050 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.912692e-01 | 0.050 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.929145e-01 | 0.049 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.957132e-01 | 0.048 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.957132e-01 | 0.048 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.957132e-01 | 0.048 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.957132e-01 | 0.048 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.957132e-01 | 0.048 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.957132e-01 | 0.048 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.957132e-01 | 0.048 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.957132e-01 | 0.048 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.962721e-01 | 0.048 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.962721e-01 | 0.048 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.975622e-01 | 0.047 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.994214e-01 | 0.046 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.994214e-01 | 0.046 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.994214e-01 | 0.046 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.994214e-01 | 0.046 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.020200e-01 | 0.045 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.049719e-01 | 0.043 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.052070e-01 | 0.043 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.052070e-01 | 0.043 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.058708e-01 | 0.043 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.068659e-01 | 0.042 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.068659e-01 | 0.042 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.068659e-01 | 0.042 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.068659e-01 | 0.042 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.068659e-01 | 0.042 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.068659e-01 | 0.042 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.068659e-01 | 0.042 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.114917e-01 | 0.040 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.127582e-01 | 0.040 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.140916e-01 | 0.039 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.140916e-01 | 0.039 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.149299e-01 | 0.039 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.168265e-01 | 0.038 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.168265e-01 | 0.038 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.168265e-01 | 0.038 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.168265e-01 | 0.038 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.209575e-01 | 0.036 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.209575e-01 | 0.036 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.209575e-01 | 0.036 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.209575e-01 | 0.036 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.209575e-01 | 0.036 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.218643e-01 | 0.035 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.220282e-01 | 0.035 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.238133e-01 | 0.034 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.245018e-01 | 0.034 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.245018e-01 | 0.034 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.257223e-01 | 0.034 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.257223e-01 | 0.034 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.257223e-01 | 0.034 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.257223e-01 | 0.034 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.266395e-01 | 0.033 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.266395e-01 | 0.033 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.272248e-01 | 0.033 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.284047e-01 | 0.032 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.292047e-01 | 0.032 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.321859e-01 | 0.030 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.324678e-01 | 0.030 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.336671e-01 | 0.030 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.336671e-01 | 0.030 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.336671e-01 | 0.030 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.336671e-01 | 0.030 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.336671e-01 | 0.030 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.336671e-01 | 0.030 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.336671e-01 | 0.030 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.336671e-01 | 0.030 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.342181e-01 | 0.030 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.346242e-01 | 0.029 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.348033e-01 | 0.029 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.377393e-01 | 0.028 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.396082e-01 | 0.027 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.400298e-01 | 0.027 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.400298e-01 | 0.027 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.407626e-01 | 0.027 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.407626e-01 | 0.027 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.407626e-01 | 0.027 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.407626e-01 | 0.027 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 9.407626e-01 | 0.027 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.407626e-01 | 0.027 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.424932e-01 | 0.026 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.430881e-01 | 0.025 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.438131e-01 | 0.025 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.438131e-01 | 0.025 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.442168e-01 | 0.025 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.453512e-01 | 0.024 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.453512e-01 | 0.024 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.468536e-01 | 0.024 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.470995e-01 | 0.024 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.470995e-01 | 0.024 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.470995e-01 | 0.024 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.470995e-01 | 0.024 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.470995e-01 | 0.024 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.470995e-01 | 0.024 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.470995e-01 | 0.024 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.471584e-01 | 0.024 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.502209e-01 | 0.022 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.502209e-01 | 0.022 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.502209e-01 | 0.022 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.502209e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.502209e-01 | 0.022 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.502209e-01 | 0.022 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.513539e-01 | 0.022 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.516711e-01 | 0.022 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.527588e-01 | 0.021 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.527588e-01 | 0.021 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.527588e-01 | 0.021 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.527588e-01 | 0.021 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.527588e-01 | 0.021 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.529962e-01 | 0.021 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.536695e-01 | 0.021 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.546745e-01 | 0.020 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.546745e-01 | 0.020 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.546745e-01 | 0.020 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.546745e-01 | 0.020 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.546745e-01 | 0.020 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.565624e-01 | 0.019 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.565624e-01 | 0.019 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.578129e-01 | 0.019 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.578129e-01 | 0.019 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.578129e-01 | 0.019 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.578129e-01 | 0.019 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.578129e-01 | 0.019 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.584813e-01 | 0.018 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.585067e-01 | 0.018 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.585067e-01 | 0.018 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.587452e-01 | 0.018 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.596356e-01 | 0.018 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.602568e-01 | 0.018 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.621475e-01 | 0.017 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.623267e-01 | 0.017 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.623267e-01 | 0.017 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.623267e-01 | 0.017 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.623267e-01 | 0.017 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 9.623267e-01 | 0.017 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.624641e-01 | 0.017 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.624641e-01 | 0.017 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.652139e-01 | 0.015 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.652139e-01 | 0.015 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.653926e-01 | 0.015 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.658598e-01 | 0.015 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.663577e-01 | 0.015 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.663577e-01 | 0.015 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.663577e-01 | 0.015 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.663577e-01 | 0.015 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.663577e-01 | 0.015 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.663577e-01 | 0.015 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.663577e-01 | 0.015 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.663577e-01 | 0.015 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.667696e-01 | 0.015 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.670988e-01 | 0.015 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.687311e-01 | 0.014 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.689588e-01 | 0.014 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.689588e-01 | 0.014 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.689588e-01 | 0.014 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.689701e-01 | 0.014 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.694296e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.695730e-01 | 0.013 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.699195e-01 | 0.013 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.699576e-01 | 0.013 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.699576e-01 | 0.013 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.699576e-01 | 0.013 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.699576e-01 | 0.013 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.699576e-01 | 0.013 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.699576e-01 | 0.013 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.707957e-01 | 0.013 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.717857e-01 | 0.012 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.717857e-01 | 0.012 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.730179e-01 | 0.012 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.731725e-01 | 0.012 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.731725e-01 | 0.012 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.731725e-01 | 0.012 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.731725e-01 | 0.012 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.731725e-01 | 0.012 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.743473e-01 | 0.011 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.743633e-01 | 0.011 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.743633e-01 | 0.011 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.759913e-01 | 0.011 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.760029e-01 | 0.011 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.760435e-01 | 0.011 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.760435e-01 | 0.011 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.760435e-01 | 0.011 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.760435e-01 | 0.011 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.760435e-01 | 0.011 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.760435e-01 | 0.011 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.760435e-01 | 0.011 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.760435e-01 | 0.011 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.765205e-01 | 0.010 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.767126e-01 | 0.010 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.767126e-01 | 0.010 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.767126e-01 | 0.010 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.767126e-01 | 0.010 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.773332e-01 | 0.010 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.778314e-01 | 0.010 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.778603e-01 | 0.010 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.786074e-01 | 0.009 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.786074e-01 | 0.009 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.786074e-01 | 0.009 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.786074e-01 | 0.009 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.786074e-01 | 0.009 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.788528e-01 | 0.009 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.795380e-01 | 0.009 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.796188e-01 | 0.009 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.808018e-01 | 0.008 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.808018e-01 | 0.008 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.808018e-01 | 0.008 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.808018e-01 | 0.008 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.808971e-01 | 0.008 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.808971e-01 | 0.008 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.809513e-01 | 0.008 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.817206e-01 | 0.008 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.817206e-01 | 0.008 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.825466e-01 | 0.008 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.825760e-01 | 0.008 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.829418e-01 | 0.007 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.835601e-01 | 0.007 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.841905e-01 | 0.007 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.841905e-01 | 0.007 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.841905e-01 | 0.007 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.842911e-01 | 0.007 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.857786e-01 | 0.006 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.860996e-01 | 0.006 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.860996e-01 | 0.006 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.863984e-01 | 0.006 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.863984e-01 | 0.006 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.863984e-01 | 0.006 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.863984e-01 | 0.006 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.868553e-01 | 0.006 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.874396e-01 | 0.005 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.878545e-01 | 0.005 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.878545e-01 | 0.005 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.882087e-01 | 0.005 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.884776e-01 | 0.005 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.887427e-01 | 0.005 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.890817e-01 | 0.005 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.890817e-01 | 0.005 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.890817e-01 | 0.005 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.891548e-01 | 0.005 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.891548e-01 | 0.005 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.891548e-01 | 0.005 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.893119e-01 | 0.005 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.893119e-01 | 0.005 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.893535e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.895871e-01 | 0.005 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.903141e-01 | 0.004 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.903141e-01 | 0.004 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.903141e-01 | 0.004 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.903160e-01 | 0.004 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.903160e-01 | 0.004 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.903160e-01 | 0.004 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.903160e-01 | 0.004 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.903160e-01 | 0.004 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.903160e-01 | 0.004 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.903160e-01 | 0.004 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.903712e-01 | 0.004 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.912243e-01 | 0.004 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.913529e-01 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.914283e-01 | 0.004 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.917742e-01 | 0.004 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.922788e-01 | 0.003 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.923439e-01 | 0.003 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.928009e-01 | 0.003 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.931057e-01 | 0.003 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.931057e-01 | 0.003 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.931057e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.931057e-01 | 0.003 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.931057e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.931057e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.931057e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.931057e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.934656e-01 | 0.003 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.934656e-01 | 0.003 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.934656e-01 | 0.003 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.937342e-01 | 0.003 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.938440e-01 | 0.003 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.938440e-01 | 0.003 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.938440e-01 | 0.003 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.940178e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.944795e-01 | 0.002 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.945033e-01 | 0.002 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.945033e-01 | 0.002 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.950141e-01 | 0.002 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.950529e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.950920e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.954658e-01 | 0.002 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.955834e-01 | 0.002 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.956177e-01 | 0.002 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.956177e-01 | 0.002 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.956177e-01 | 0.002 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.956177e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.956273e-01 | 0.002 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.957325e-01 | 0.002 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.960872e-01 | 0.002 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.960872e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.960872e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.961089e-01 | 0.002 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.961145e-01 | 0.002 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.961470e-01 | 0.002 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.961727e-01 | 0.002 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.961727e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.962285e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.963470e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.963470e-01 | 0.002 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.964225e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.964225e-01 | 0.002 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.965063e-01 | 0.002 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.965063e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.965614e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.965614e-01 | 0.001 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.965800e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.967595e-01 | 0.001 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.968806e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.968806e-01 | 0.001 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.968806e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.971242e-01 | 0.001 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.972148e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.972148e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.973976e-01 | 0.001 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.975132e-01 | 0.001 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.975132e-01 | 0.001 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.975132e-01 | 0.001 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.975132e-01 | 0.001 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.975132e-01 | 0.001 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.975132e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.975629e-01 | 0.001 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.975629e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.977143e-01 | 0.001 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.977797e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.977797e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.978634e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.980176e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.980488e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.980488e-01 | 0.001 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.982300e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.982372e-01 | 0.001 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.982372e-01 | 0.001 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.983711e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.984197e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.984197e-01 | 0.001 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.985619e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.985619e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.986109e-01 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.986551e-01 | 0.001 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.987014e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.987014e-01 | 0.001 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.987403e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.987636e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.988749e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.988841e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.989415e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.989415e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.989959e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.991376e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.991878e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.992045e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.992378e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.992823e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.992855e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.993073e-01 | 0.000 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.994305e-01 | 0.000 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.994807e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.994915e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.995284e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.995284e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.995461e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.995461e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.995461e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.995934e-01 | 0.000 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.995948e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.995948e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.995948e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.996049e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.996219e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.996382e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.997117e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.997119e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.997205e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997379e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.997503e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.997604e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.997750e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997949e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997949e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998045e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.998354e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.998434e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998541e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998582e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998697e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998837e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.998961e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999010e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999024e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999073e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999145e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999177e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999228e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.999412e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999522e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999563e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999581e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999659e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999702e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999760e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999820e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999820e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999904e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999907e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999925e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999939e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999946e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999957e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999963e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999981e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999988e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999989e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999990e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999991e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999992e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999996e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999996e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999998e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999999e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.108624e-15 | 14.507 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.086420e-14 | 13.511 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.572520e-14 | 13.182 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.065814e-13 | 12.972 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.005862e-13 | 12.997 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.344480e-13 | 12.871 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.429612e-13 | 12.129 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.998358e-13 | 12.046 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.018630e-12 | 11.992 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.219447e-12 | 11.654 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.673572e-11 | 10.573 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.691714e-11 | 10.570 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.128164e-11 | 10.384 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.601562e-10 | 9.585 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.605624e-10 | 9.337 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.422857e-08 | 7.847 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.691168e-08 | 7.772 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.614006e-08 | 7.792 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.944677e-08 | 7.531 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.944677e-08 | 7.531 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.916058e-08 | 7.407 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.987812e-08 | 7.098 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.579524e-08 | 7.067 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.662808e-07 | 6.779 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.672550e-07 | 6.777 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.942440e-07 | 6.712 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.256347e-07 | 6.647 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.256347e-07 | 6.647 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.993518e-07 | 6.524 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.690149e-07 | 6.433 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.590807e-07 | 6.338 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.402395e-07 | 6.194 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.968186e-07 | 6.099 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.234426e-06 | 5.909 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.360290e-06 | 5.866 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.715716e-06 | 5.766 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.695232e-06 | 5.771 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.899683e-06 | 5.721 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.077377e-06 | 5.682 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.946834e-06 | 5.531 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.221252e-06 | 5.492 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.846031e-06 | 5.415 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.194603e-06 | 5.284 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.731246e-06 | 5.242 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.106234e-06 | 5.148 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.018279e-06 | 5.154 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.921510e-06 | 5.101 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.218695e-06 | 5.085 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.484937e-06 | 5.071 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.153366e-05 | 4.938 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.207354e-05 | 4.918 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.208158e-05 | 4.918 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.230565e-05 | 4.910 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.233732e-05 | 4.909 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.383095e-05 | 4.859 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.536086e-05 | 4.814 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.673431e-05 | 4.776 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.673431e-05 | 4.776 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.081522e-05 | 4.682 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.575433e-05 | 4.589 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.503040e-05 | 4.602 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.605337e-05 | 4.584 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.683226e-05 | 4.571 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.683226e-05 | 4.571 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.769330e-05 | 4.558 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.497022e-05 | 4.456 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.536806e-05 | 4.451 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.641775e-05 | 4.439 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.888913e-05 | 4.410 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.537716e-05 | 4.343 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.790740e-05 | 4.320 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.746549e-05 | 4.324 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.790740e-05 | 4.320 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.019378e-05 | 4.299 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.117007e-05 | 4.291 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.942350e-05 | 4.226 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.942350e-05 | 4.226 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.244757e-05 | 4.204 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.244757e-05 | 4.204 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.675964e-05 | 4.175 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.387136e-05 | 4.195 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.126749e-05 | 4.147 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.013533e-05 | 4.045 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.555117e-05 | 4.020 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.836083e-05 | 4.007 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.865643e-05 | 4.006 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.134975e-04 | 3.945 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.174994e-04 | 3.930 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.293161e-04 | 3.888 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.317519e-04 | 3.880 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.334262e-04 | 3.875 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.387290e-04 | 3.858 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.394195e-04 | 3.856 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.659397e-04 | 3.780 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.672413e-04 | 3.777 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.675411e-04 | 3.776 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.885284e-04 | 3.725 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.964272e-04 | 3.707 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.003241e-04 | 3.698 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.135106e-04 | 3.671 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.079125e-04 | 3.682 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.288641e-04 | 3.640 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.547549e-04 | 3.594 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.587209e-04 | 3.587 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.596438e-04 | 3.586 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.662133e-04 | 3.575 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.799050e-04 | 3.553 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.887277e-04 | 3.540 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.887277e-04 | 3.540 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.138445e-04 | 3.503 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.198398e-04 | 3.495 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.294267e-04 | 3.482 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.320088e-04 | 3.479 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.320088e-04 | 3.479 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.357375e-04 | 3.474 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.626910e-04 | 3.440 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.639793e-04 | 3.439 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.992484e-04 | 3.399 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.992484e-04 | 3.399 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.097780e-04 | 3.387 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.099625e-04 | 3.387 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.099625e-04 | 3.387 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.099625e-04 | 3.387 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.099625e-04 | 3.387 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.174718e-04 | 3.379 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.492312e-04 | 3.348 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.506662e-04 | 3.346 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.798027e-04 | 3.319 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.937642e-04 | 3.306 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.650021e-04 | 3.333 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.593590e-04 | 3.338 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.798027e-04 | 3.319 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.995831e-04 | 3.301 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.002225e-04 | 3.301 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.168494e-04 | 3.287 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.168494e-04 | 3.287 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.421538e-04 | 3.266 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.459784e-04 | 3.263 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.607325e-04 | 3.251 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.645203e-04 | 3.248 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.297453e-04 | 3.201 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.297453e-04 | 3.201 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.794916e-04 | 3.237 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.403245e-04 | 3.194 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.439986e-04 | 3.191 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.678970e-04 | 3.175 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.071402e-04 | 3.150 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 7.268697e-04 | 3.139 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 7.268697e-04 | 3.139 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.271457e-04 | 3.138 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.665934e-04 | 3.115 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.756806e-04 | 3.110 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.798041e-04 | 3.108 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.815190e-04 | 3.107 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.357447e-04 | 3.078 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 8.704687e-04 | 3.060 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.357447e-04 | 3.078 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.845214e-04 | 3.053 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.280595e-04 | 3.082 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.936283e-04 | 3.049 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.626921e-04 | 3.017 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.006826e-03 | 2.997 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.009238e-03 | 2.996 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.009238e-03 | 2.996 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.061719e-03 | 2.974 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.225568e-03 | 2.912 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.225568e-03 | 2.912 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.177514e-03 | 2.929 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.199949e-03 | 2.921 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.199949e-03 | 2.921 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.166559e-03 | 2.933 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.115158e-03 | 2.953 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.207002e-03 | 2.918 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.111628e-03 | 2.954 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.231016e-03 | 2.910 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.231016e-03 | 2.910 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.136727e-03 | 2.944 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.199949e-03 | 2.921 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.207002e-03 | 2.918 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.241137e-03 | 2.906 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.266685e-03 | 2.897 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.271698e-03 | 2.896 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.297383e-03 | 2.887 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.297383e-03 | 2.887 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.322815e-03 | 2.879 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.430612e-03 | 2.844 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.480790e-03 | 2.830 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.504092e-03 | 2.823 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.591380e-03 | 2.798 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.643053e-03 | 2.784 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.655977e-03 | 2.781 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.695571e-03 | 2.771 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.697903e-03 | 2.770 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.699479e-03 | 2.770 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.720527e-03 | 2.764 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.772341e-03 | 2.751 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.793313e-03 | 2.746 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.885789e-03 | 2.725 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.907283e-03 | 2.720 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.992652e-03 | 2.701 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.045007e-03 | 2.689 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.045007e-03 | 2.689 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.038208e-03 | 2.691 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.297136e-03 | 2.639 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.322851e-03 | 2.634 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.330453e-03 | 2.633 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.398980e-03 | 2.620 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.496816e-03 | 2.603 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.802958e-03 | 2.552 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.818926e-03 | 2.550 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.920452e-03 | 2.535 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.920452e-03 | 2.535 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.939396e-03 | 2.532 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.130651e-03 | 2.504 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.139898e-03 | 2.503 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.148987e-03 | 2.502 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.386951e-03 | 2.470 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.401924e-03 | 2.468 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.411119e-03 | 2.467 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.458791e-03 | 2.461 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.486871e-03 | 2.458 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.551507e-03 | 2.450 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.617010e-03 | 2.442 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.823018e-03 | 2.418 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.050639e-03 | 2.392 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.097982e-03 | 2.387 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.097982e-03 | 2.387 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.097982e-03 | 2.387 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.809516e-03 | 2.318 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.809516e-03 | 2.318 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.742016e-03 | 2.324 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.417207e-03 | 2.355 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.854004e-03 | 2.314 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.226804e-03 | 2.374 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.473248e-03 | 2.349 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.699310e-03 | 2.328 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.672391e-03 | 2.330 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.824064e-03 | 2.317 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.991783e-03 | 2.302 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.991783e-03 | 2.302 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.059761e-03 | 2.296 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.059761e-03 | 2.296 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.072999e-03 | 2.295 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.111777e-03 | 2.291 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.111777e-03 | 2.291 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.253827e-03 | 2.280 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.342499e-03 | 2.272 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.342499e-03 | 2.272 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.342499e-03 | 2.272 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.370016e-03 | 2.270 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.497317e-03 | 2.260 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.497317e-03 | 2.260 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.563575e-03 | 2.255 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.563575e-03 | 2.255 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.563575e-03 | 2.255 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.773369e-03 | 2.239 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.853811e-03 | 2.233 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.980129e-03 | 2.223 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.980129e-03 | 2.223 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.111550e-03 | 2.214 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.111550e-03 | 2.214 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.111550e-03 | 2.214 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.182156e-03 | 2.209 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.186713e-03 | 2.209 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.186713e-03 | 2.209 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.186713e-03 | 2.209 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.197208e-03 | 2.208 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.221246e-03 | 2.141 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 7.379367e-03 | 2.132 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.355444e-03 | 2.133 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.435071e-03 | 2.129 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.848054e-03 | 2.164 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.475886e-03 | 2.189 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.070625e-03 | 2.151 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.449587e-03 | 2.128 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.848054e-03 | 2.164 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.810729e-03 | 2.167 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.297294e-03 | 2.137 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.350967e-03 | 2.134 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.379367e-03 | 2.132 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.379702e-03 | 2.195 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.163207e-03 | 2.145 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.502241e-03 | 2.125 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 7.570146e-03 | 2.121 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 7.570146e-03 | 2.121 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.672090e-03 | 2.115 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.824202e-03 | 2.107 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.958774e-03 | 2.099 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.346435e-03 | 2.078 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.370957e-03 | 2.077 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.519197e-03 | 2.070 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 8.559007e-03 | 2.068 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.559007e-03 | 2.068 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 8.559007e-03 | 2.068 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.567512e-03 | 2.067 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.567512e-03 | 2.067 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 8.567512e-03 | 2.067 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.567512e-03 | 2.067 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 8.567512e-03 | 2.067 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.810559e-03 | 2.055 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.867059e-03 | 2.052 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.867059e-03 | 2.052 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.204574e-03 | 2.036 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.282357e-03 | 2.032 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.902008e-03 | 2.004 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.955448e-03 | 2.002 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 9.955448e-03 | 2.002 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 9.955448e-03 | 2.002 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.061623e-02 | 1.974 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.301084e-02 | 1.886 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.080392e-02 | 1.966 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.080392e-02 | 1.966 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.234600e-02 | 1.908 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.059569e-02 | 1.975 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.059569e-02 | 1.975 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.059569e-02 | 1.975 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.094241e-02 | 1.961 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.214249e-02 | 1.916 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.223139e-02 | 1.913 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.152528e-02 | 1.938 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.152528e-02 | 1.938 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.061623e-02 | 1.974 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.112180e-02 | 1.954 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.059569e-02 | 1.975 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.193832e-02 | 1.923 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.251126e-02 | 1.903 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.149958e-02 | 1.939 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.216244e-02 | 1.915 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.193832e-02 | 1.923 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.223139e-02 | 1.913 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.223139e-02 | 1.913 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.223139e-02 | 1.913 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.301084e-02 | 1.886 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.061623e-02 | 1.974 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.202633e-02 | 1.920 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.223139e-02 | 1.913 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.256969e-02 | 1.901 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.052382e-02 | 1.978 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.134628e-02 | 1.945 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.058205e-02 | 1.975 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.109681e-02 | 1.955 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.049868e-02 | 1.979 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.202633e-02 | 1.920 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.321153e-02 | 1.879 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.331917e-02 | 1.876 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.375881e-02 | 1.861 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.385538e-02 | 1.858 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.442147e-02 | 1.841 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.442499e-02 | 1.841 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.491043e-02 | 1.827 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.491910e-02 | 1.826 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.532224e-02 | 1.815 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.532224e-02 | 1.815 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.534877e-02 | 1.814 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.594477e-02 | 1.797 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.620240e-02 | 1.790 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.668012e-02 | 1.778 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.675145e-02 | 1.776 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.698366e-02 | 1.770 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.698366e-02 | 1.770 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.736289e-02 | 1.760 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.746984e-02 | 1.758 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.777628e-02 | 1.750 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.782094e-02 | 1.749 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.794810e-02 | 1.746 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.796594e-02 | 1.746 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.892145e-02 | 1.723 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.892145e-02 | 1.723 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.901514e-02 | 1.721 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.944448e-02 | 1.711 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.992905e-02 | 1.701 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.996063e-02 | 1.700 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.022724e-02 | 1.694 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.107248e-02 | 1.676 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.144129e-02 | 1.669 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.220585e-02 | 1.654 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.220585e-02 | 1.654 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.220585e-02 | 1.654 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.220797e-02 | 1.653 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.220797e-02 | 1.653 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.220797e-02 | 1.653 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.248877e-02 | 1.648 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.263551e-02 | 1.645 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.267723e-02 | 1.644 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.315077e-02 | 1.635 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.373170e-02 | 1.625 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.438886e-02 | 1.613 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.438886e-02 | 1.613 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.438886e-02 | 1.613 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.438886e-02 | 1.613 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.438886e-02 | 1.613 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.789944e-02 | 1.554 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.789944e-02 | 1.554 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.649547e-02 | 1.577 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.233170e-02 | 1.490 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.233170e-02 | 1.490 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.156659e-02 | 1.501 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.536735e-02 | 1.596 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.203676e-02 | 1.494 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.819454e-02 | 1.550 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.819454e-02 | 1.550 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.517010e-02 | 1.599 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.629361e-02 | 1.580 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.649547e-02 | 1.577 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.261636e-02 | 1.487 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.527136e-02 | 1.597 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.233170e-02 | 1.490 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.699633e-02 | 1.569 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.203676e-02 | 1.494 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.733921e-02 | 1.563 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.203676e-02 | 1.494 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.203676e-02 | 1.494 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.780749e-02 | 1.556 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.799423e-02 | 1.553 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.203676e-02 | 1.494 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.819454e-02 | 1.550 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.874730e-02 | 1.541 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.649547e-02 | 1.577 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.629361e-02 | 1.580 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.261636e-02 | 1.487 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.087316e-02 | 1.510 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.273148e-02 | 1.485 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.286652e-02 | 1.483 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.324944e-02 | 1.478 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.392761e-02 | 1.469 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.423233e-02 | 1.466 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.423233e-02 | 1.466 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.475520e-02 | 1.459 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.569784e-02 | 1.447 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.583920e-02 | 1.446 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.590863e-02 | 1.445 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.673064e-02 | 1.435 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.731374e-02 | 1.428 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.732525e-02 | 1.428 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.801505e-02 | 1.420 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.922256e-02 | 1.406 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.997904e-02 | 1.398 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.997904e-02 | 1.398 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.997904e-02 | 1.398 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.093865e-02 | 1.388 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.093865e-02 | 1.388 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.118617e-02 | 1.385 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.134989e-02 | 1.384 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.150565e-02 | 1.382 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.150565e-02 | 1.382 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.150565e-02 | 1.382 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.150565e-02 | 1.382 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.150565e-02 | 1.382 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.177867e-02 | 1.379 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.208595e-02 | 1.376 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.208595e-02 | 1.376 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.232310e-02 | 1.373 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.278661e-02 | 1.369 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.431110e-02 | 1.353 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.540928e-02 | 1.343 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.551988e-02 | 1.342 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 4.583603e-02 | 1.339 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.599263e-02 | 1.337 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.729976e-02 | 1.325 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.729976e-02 | 1.325 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.729976e-02 | 1.325 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.797461e-02 | 1.319 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.835075e-02 | 1.316 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.895070e-02 | 1.310 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.936047e-02 | 1.307 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.949208e-02 | 1.305 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.949208e-02 | 1.305 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.964379e-02 | 1.304 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.964379e-02 | 1.304 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.002177e-02 | 1.301 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.110279e-02 | 1.292 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.110279e-02 | 1.292 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.115848e-02 | 1.291 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.289439e-02 | 1.277 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.289439e-02 | 1.277 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.289439e-02 | 1.277 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.310237e-02 | 1.275 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.310237e-02 | 1.275 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.310237e-02 | 1.275 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.375506e-02 | 1.270 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.388750e-02 | 1.269 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.388750e-02 | 1.269 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.568776e-02 | 1.254 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.669092e-02 | 1.246 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.669092e-02 | 1.246 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.674513e-02 | 1.246 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.828487e-02 | 1.234 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.865420e-02 | 1.232 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.865420e-02 | 1.232 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 5.910039e-02 | 1.228 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.910039e-02 | 1.228 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.917863e-02 | 1.228 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.978890e-02 | 1.223 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.978890e-02 | 1.223 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 5.978890e-02 | 1.223 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 5.978890e-02 | 1.223 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.978890e-02 | 1.223 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 5.978890e-02 | 1.223 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 5.978890e-02 | 1.223 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.978890e-02 | 1.223 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.978890e-02 | 1.223 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.978890e-02 | 1.223 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.978890e-02 | 1.223 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.978890e-02 | 1.223 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.978890e-02 | 1.223 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.978890e-02 | 1.223 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.978890e-02 | 1.223 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.978890e-02 | 1.223 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 5.978890e-02 | 1.223 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 8.771395e-02 | 1.057 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 8.771395e-02 | 1.057 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 8.771395e-02 | 1.057 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 8.771395e-02 | 1.057 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.040800e-02 | 1.219 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.726477e-02 | 1.112 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.726477e-02 | 1.112 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.515766e-02 | 1.124 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.897779e-02 | 1.051 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.927938e-02 | 1.101 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.076510e-02 | 1.216 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.355775e-02 | 1.078 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.675156e-02 | 1.115 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.454407e-02 | 1.190 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.947122e-02 | 1.100 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.878127e-02 | 1.052 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.792975e-02 | 1.056 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.065816e-02 | 1.093 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.366796e-02 | 1.077 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.454513e-02 | 1.073 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.897779e-02 | 1.051 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.635513e-02 | 1.117 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.635513e-02 | 1.117 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.749533e-02 | 1.171 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.040800e-02 | 1.219 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.283675e-02 | 1.138 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.760041e-02 | 1.057 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.355775e-02 | 1.078 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.259581e-02 | 1.203 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.726477e-02 | 1.112 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.050652e-02 | 1.152 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.727746e-02 | 1.172 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.258313e-02 | 1.083 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 8.771395e-02 | 1.057 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.251841e-02 | 1.204 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.853581e-02 | 1.164 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.459899e-02 | 1.127 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.209931e-02 | 1.086 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.991859e-02 | 1.097 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.681665e-02 | 1.175 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.635513e-02 | 1.117 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.146277e-02 | 1.211 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.726477e-02 | 1.112 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.878127e-02 | 1.052 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.574663e-02 | 1.182 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.887268e-02 | 1.103 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.635513e-02 | 1.117 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.515766e-02 | 1.124 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.515766e-02 | 1.124 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.102935e-02 | 1.214 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.887268e-02 | 1.103 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.887268e-02 | 1.103 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.312044e-02 | 1.080 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.629478e-02 | 1.179 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.515766e-02 | 1.124 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.515766e-02 | 1.124 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.574663e-02 | 1.182 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.320418e-02 | 1.199 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.259581e-02 | 1.203 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.259581e-02 | 1.203 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.923918e-02 | 1.049 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.000868e-02 | 1.046 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.000868e-02 | 1.046 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 9.000868e-02 | 1.046 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.086809e-02 | 1.042 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.086809e-02 | 1.042 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.193468e-02 | 1.037 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 9.368633e-02 | 1.028 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 9.368633e-02 | 1.028 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 9.368633e-02 | 1.028 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.368633e-02 | 1.028 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 9.368633e-02 | 1.028 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.368633e-02 | 1.028 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 9.368633e-02 | 1.028 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 9.368633e-02 | 1.028 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 9.368633e-02 | 1.028 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 9.368633e-02 | 1.028 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.368633e-02 | 1.028 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 9.368633e-02 | 1.028 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.407367e-02 | 1.027 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 9.407367e-02 | 1.027 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.407367e-02 | 1.027 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.558061e-02 | 1.020 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 9.593022e-02 | 1.018 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.593022e-02 | 1.018 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 9.593022e-02 | 1.018 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 9.593022e-02 | 1.018 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.593022e-02 | 1.018 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.593022e-02 | 1.018 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.677737e-02 | 1.014 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.677737e-02 | 1.014 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.677737e-02 | 1.014 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.828095e-02 | 1.008 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.000739e-01 | 1.000 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.021883e-01 | 0.991 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.032781e-01 | 0.986 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.032781e-01 | 0.986 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.037198e-01 | 0.984 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.039233e-01 | 0.983 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 1.039233e-01 | 0.983 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.039233e-01 | 0.983 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.039233e-01 | 0.983 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.039233e-01 | 0.983 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 1.039233e-01 | 0.983 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.053374e-01 | 0.977 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.056401e-01 | 0.976 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.056401e-01 | 0.976 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.056401e-01 | 0.976 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.105203e-01 | 0.957 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.105203e-01 | 0.957 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.118905e-01 | 0.951 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.138790e-01 | 0.944 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.138790e-01 | 0.944 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.138790e-01 | 0.944 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.138790e-01 | 0.944 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.149356e-01 | 0.940 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.161987e-01 | 0.935 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.162253e-01 | 0.935 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.162253e-01 | 0.935 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.162253e-01 | 0.935 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.162253e-01 | 0.935 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.164793e-01 | 0.934 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.164793e-01 | 0.934 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.164793e-01 | 0.934 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.186602e-01 | 0.926 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.186602e-01 | 0.926 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.186602e-01 | 0.926 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.186602e-01 | 0.926 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.199279e-01 | 0.921 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.199279e-01 | 0.921 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.204562e-01 | 0.919 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.207586e-01 | 0.918 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.215074e-01 | 0.915 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.223179e-01 | 0.913 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.232385e-01 | 0.909 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.235976e-01 | 0.908 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.245395e-01 | 0.905 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.245395e-01 | 0.905 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.269607e-01 | 0.896 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.269607e-01 | 0.896 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.304358e-01 | 0.885 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.342529e-01 | 0.872 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.347062e-01 | 0.871 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.347062e-01 | 0.871 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.347913e-01 | 0.870 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.347913e-01 | 0.870 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.351909e-01 | 0.869 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.356869e-01 | 0.867 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.369170e-01 | 0.864 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.369170e-01 | 0.864 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.369170e-01 | 0.864 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.379141e-01 | 0.860 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.379599e-01 | 0.860 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 1.379599e-01 | 0.860 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.409247e-01 | 0.851 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.424196e-01 | 0.846 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.424196e-01 | 0.846 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.786005e-01 | 0.748 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.786005e-01 | 0.748 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.786005e-01 | 0.748 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.786005e-01 | 0.748 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 1.786005e-01 | 0.748 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 1.786005e-01 | 0.748 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.786005e-01 | 0.748 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.786005e-01 | 0.748 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.786005e-01 | 0.748 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.786005e-01 | 0.748 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 1.786005e-01 | 0.748 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 2.555635e-01 | 0.593 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 2.555635e-01 | 0.593 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.555635e-01 | 0.593 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.555635e-01 | 0.593 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 2.555635e-01 | 0.593 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.555635e-01 | 0.593 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 2.555635e-01 | 0.593 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.555635e-01 | 0.593 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.555635e-01 | 0.593 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.518174e-01 | 0.819 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.518174e-01 | 0.819 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.518174e-01 | 0.819 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.518174e-01 | 0.819 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.518174e-01 | 0.819 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.865001e-01 | 0.729 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.865001e-01 | 0.729 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.865001e-01 | 0.729 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.221320e-01 | 0.653 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.582312e-01 | 0.588 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.582312e-01 | 0.588 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.582312e-01 | 0.588 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.582312e-01 | 0.588 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.582312e-01 | 0.588 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.098565e-01 | 0.678 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.098565e-01 | 0.678 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.735181e-01 | 0.761 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.735181e-01 | 0.761 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.354205e-01 | 0.628 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.614858e-01 | 0.583 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.878887e-01 | 0.541 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 2.878887e-01 | 0.541 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.099929e-01 | 0.678 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.547134e-01 | 0.594 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.275051e-01 | 0.643 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.761475e-01 | 0.559 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.524088e-01 | 0.817 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.792360e-01 | 0.747 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.843385e-01 | 0.734 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.664654e-01 | 0.779 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.599483e-01 | 0.796 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.423647e-01 | 0.616 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.558099e-01 | 0.592 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.845034e-01 | 0.546 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.833500e-01 | 0.548 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.808368e-01 | 0.552 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.198598e-01 | 0.658 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.317352e-01 | 0.635 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.550328e-01 | 0.593 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.550328e-01 | 0.593 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.822594e-01 | 0.549 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.476603e-01 | 0.831 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.099929e-01 | 0.678 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.849682e-01 | 0.733 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.451070e-01 | 0.838 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.354205e-01 | 0.628 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 2.454242e-01 | 0.610 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.518174e-01 | 0.819 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.751516e-01 | 0.757 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.423647e-01 | 0.616 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.499953e-01 | 0.602 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.483205e-01 | 0.605 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.558179e-01 | 0.592 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.562609e-01 | 0.806 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.844212e-01 | 0.734 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 1.518174e-01 | 0.819 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.098565e-01 | 0.678 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 2.354205e-01 | 0.628 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.749711e-01 | 0.757 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.767017e-01 | 0.753 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.767017e-01 | 0.753 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.636942e-01 | 0.579 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.156389e-01 | 0.666 | 0 | 0 |
| Translation | R-HSA-72766 | 1.701663e-01 | 0.769 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.822594e-01 | 0.549 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.902279e-01 | 0.721 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.515634e-01 | 0.599 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.518174e-01 | 0.819 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.865001e-01 | 0.729 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 1.865001e-01 | 0.729 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.614858e-01 | 0.583 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.792360e-01 | 0.747 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.098565e-01 | 0.678 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.822594e-01 | 0.549 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.865001e-01 | 0.729 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.929543e-01 | 0.715 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.099929e-01 | 0.678 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.547482e-01 | 0.594 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.537013e-01 | 0.596 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.912482e-01 | 0.718 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.221320e-01 | 0.653 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.896258e-01 | 0.722 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.902279e-01 | 0.721 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.148096e-01 | 0.668 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.562609e-01 | 0.806 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.453306e-01 | 0.838 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.453306e-01 | 0.838 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.273534e-01 | 0.643 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.786005e-01 | 0.748 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.555635e-01 | 0.593 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 1.865001e-01 | 0.729 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 1.865001e-01 | 0.729 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.582312e-01 | 0.588 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 2.582312e-01 | 0.588 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.354205e-01 | 0.628 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 2.354205e-01 | 0.628 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.473049e-01 | 0.832 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.473049e-01 | 0.832 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.562609e-01 | 0.806 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.627327e-01 | 0.789 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.896258e-01 | 0.722 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 2.878887e-01 | 0.541 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.547134e-01 | 0.594 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.497320e-01 | 0.825 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.793495e-01 | 0.554 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.355467e-01 | 0.628 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.537013e-01 | 0.596 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.130266e-01 | 0.672 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.718763e-01 | 0.765 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.198598e-01 | 0.658 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.453306e-01 | 0.838 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.336433e-01 | 0.631 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.896258e-01 | 0.722 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.099929e-01 | 0.678 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.844324e-01 | 0.546 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.751516e-01 | 0.757 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.476603e-01 | 0.831 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.788774e-01 | 0.555 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.559494e-01 | 0.807 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.524851e-01 | 0.817 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.518174e-01 | 0.819 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.865001e-01 | 0.729 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.221320e-01 | 0.653 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.130266e-01 | 0.672 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.547134e-01 | 0.594 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.980839e-01 | 0.703 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.678715e-01 | 0.572 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 2.002751e-01 | 0.698 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.628898e-01 | 0.788 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.821866e-01 | 0.739 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.550328e-01 | 0.593 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.912482e-01 | 0.718 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.546147e-01 | 0.594 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.291651e-01 | 0.640 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.718763e-01 | 0.765 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.761475e-01 | 0.559 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.609392e-01 | 0.793 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.275051e-01 | 0.643 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.615373e-01 | 0.792 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.548092e-01 | 0.810 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.761475e-01 | 0.559 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.833500e-01 | 0.548 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 2.110235e-01 | 0.676 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.547134e-01 | 0.594 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.454242e-01 | 0.610 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.734529e-01 | 0.563 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.694055e-01 | 0.771 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.547134e-01 | 0.594 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.735181e-01 | 0.761 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.627327e-01 | 0.789 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.336433e-01 | 0.631 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.518174e-01 | 0.819 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 1.929543e-01 | 0.715 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.943977e-01 | 0.531 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.945146e-01 | 0.531 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.954810e-01 | 0.529 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.974004e-01 | 0.527 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.974004e-01 | 0.527 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.974004e-01 | 0.527 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.974004e-01 | 0.527 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.974004e-01 | 0.527 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.978587e-01 | 0.526 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.978587e-01 | 0.526 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.978587e-01 | 0.526 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 2.978587e-01 | 0.526 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.997543e-01 | 0.523 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.010646e-01 | 0.521 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.012074e-01 | 0.521 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.012074e-01 | 0.521 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.012074e-01 | 0.521 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.020344e-01 | 0.520 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.144775e-01 | 0.502 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.144775e-01 | 0.502 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.144775e-01 | 0.502 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 3.144775e-01 | 0.502 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 3.144775e-01 | 0.502 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.144775e-01 | 0.502 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.144775e-01 | 0.502 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.181582e-01 | 0.497 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.181582e-01 | 0.497 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.197635e-01 | 0.495 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.253194e-01 | 0.488 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.253194e-01 | 0.488 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.253194e-01 | 0.488 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.253194e-01 | 0.488 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 3.259501e-01 | 0.487 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.303022e-01 | 0.481 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.303022e-01 | 0.481 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.303022e-01 | 0.481 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.303022e-01 | 0.481 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.303022e-01 | 0.481 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.303022e-01 | 0.481 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 3.303022e-01 | 0.481 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.303022e-01 | 0.481 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.303022e-01 | 0.481 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.303022e-01 | 0.481 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 3.303022e-01 | 0.481 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.303022e-01 | 0.481 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.303022e-01 | 0.481 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.303022e-01 | 0.481 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.303022e-01 | 0.481 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.307256e-01 | 0.481 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.345520e-01 | 0.476 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.352471e-01 | 0.475 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.353580e-01 | 0.474 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.371740e-01 | 0.472 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.387509e-01 | 0.470 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.404044e-01 | 0.468 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.407764e-01 | 0.468 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.408760e-01 | 0.467 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.411125e-01 | 0.467 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.411125e-01 | 0.467 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.411125e-01 | 0.467 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 3.411125e-01 | 0.467 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.415905e-01 | 0.466 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.417819e-01 | 0.466 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 3.417819e-01 | 0.466 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.417819e-01 | 0.466 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.445562e-01 | 0.463 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.456218e-01 | 0.461 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.463890e-01 | 0.460 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.524368e-01 | 0.453 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.583862e-01 | 0.446 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.583862e-01 | 0.446 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.617465e-01 | 0.442 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.621335e-01 | 0.441 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.621335e-01 | 0.441 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.638381e-01 | 0.439 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.638381e-01 | 0.439 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 3.638381e-01 | 0.439 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 3.638381e-01 | 0.439 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.638381e-01 | 0.439 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.656765e-01 | 0.437 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.656765e-01 | 0.437 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.656765e-01 | 0.437 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.656765e-01 | 0.437 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 3.656765e-01 | 0.437 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.656765e-01 | 0.437 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.656765e-01 | 0.437 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.656765e-01 | 0.437 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.676668e-01 | 0.435 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 3.676668e-01 | 0.435 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.696911e-01 | 0.432 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 3.776253e-01 | 0.423 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.779317e-01 | 0.423 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 3.842192e-01 | 0.415 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.858609e-01 | 0.414 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.869750e-01 | 0.412 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.883816e-01 | 0.411 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 3.885427e-01 | 0.411 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 3.885427e-01 | 0.411 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.885427e-01 | 0.411 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.885427e-01 | 0.411 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.885427e-01 | 0.411 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 3.885427e-01 | 0.411 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.885427e-01 | 0.411 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 3.885427e-01 | 0.411 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 3.885427e-01 | 0.411 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.902858e-01 | 0.409 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.934092e-01 | 0.405 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.940261e-01 | 0.404 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.940261e-01 | 0.404 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.940261e-01 | 0.404 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.940261e-01 | 0.404 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 3.968503e-01 | 0.401 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.989026e-01 | 0.399 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.989026e-01 | 0.399 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.003049e-01 | 0.398 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.003049e-01 | 0.398 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.003049e-01 | 0.398 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.003049e-01 | 0.398 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.003049e-01 | 0.398 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.029335e-01 | 0.395 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.042544e-01 | 0.393 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.042544e-01 | 0.393 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.077837e-01 | 0.390 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.095832e-01 | 0.388 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.109708e-01 | 0.386 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.135903e-01 | 0.383 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.143776e-01 | 0.383 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.160164e-01 | 0.381 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.160164e-01 | 0.381 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.160164e-01 | 0.381 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.166982e-01 | 0.380 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 4.200883e-01 | 0.377 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.214966e-01 | 0.375 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.227786e-01 | 0.374 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.227786e-01 | 0.374 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.295451e-01 | 0.367 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.295451e-01 | 0.367 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.321543e-01 | 0.364 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.331109e-01 | 0.363 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.340166e-01 | 0.362 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.340166e-01 | 0.362 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.340166e-01 | 0.362 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.340166e-01 | 0.362 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.340166e-01 | 0.362 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.340166e-01 | 0.362 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.340166e-01 | 0.362 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.357314e-01 | 0.361 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.386705e-01 | 0.358 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.457634e-01 | 0.351 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.457634e-01 | 0.351 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.457634e-01 | 0.351 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.458448e-01 | 0.351 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.458448e-01 | 0.351 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.458448e-01 | 0.351 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.458448e-01 | 0.351 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.458448e-01 | 0.351 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.458448e-01 | 0.351 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.458448e-01 | 0.351 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.458448e-01 | 0.351 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.458448e-01 | 0.351 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.458448e-01 | 0.351 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.458448e-01 | 0.351 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.458448e-01 | 0.351 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.458448e-01 | 0.351 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.463302e-01 | 0.350 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.510882e-01 | 0.346 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.510882e-01 | 0.346 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.540059e-01 | 0.343 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.568203e-01 | 0.340 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.666795e-01 | 0.331 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.666795e-01 | 0.331 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.666795e-01 | 0.331 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.666795e-01 | 0.331 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.666795e-01 | 0.331 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.666795e-01 | 0.331 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.666795e-01 | 0.331 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.666795e-01 | 0.331 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.666795e-01 | 0.331 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.666795e-01 | 0.331 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.666795e-01 | 0.331 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.666795e-01 | 0.331 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.709728e-01 | 0.327 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.726960e-01 | 0.325 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.804052e-01 | 0.318 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.814727e-01 | 0.317 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.850508e-01 | 0.314 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 4.878802e-01 | 0.312 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.912874e-01 | 0.309 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.915672e-01 | 0.308 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 4.956486e-01 | 0.305 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.956486e-01 | 0.305 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.977800e-01 | 0.303 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 4.977800e-01 | 0.303 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.977800e-01 | 0.303 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.977800e-01 | 0.303 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 4.977800e-01 | 0.303 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.977800e-01 | 0.303 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.981941e-01 | 0.303 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.981941e-01 | 0.303 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.057026e-01 | 0.296 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.065640e-01 | 0.295 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.068342e-01 | 0.295 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.095785e-01 | 0.293 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.118909e-01 | 0.291 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.139168e-01 | 0.289 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.139168e-01 | 0.289 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.184000e-01 | 0.285 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.197332e-01 | 0.284 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.197332e-01 | 0.284 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.197332e-01 | 0.284 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.284889e-01 | 0.277 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.284889e-01 | 0.277 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.334108e-01 | 0.273 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.341197e-01 | 0.272 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.341197e-01 | 0.272 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.341197e-01 | 0.272 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.387293e-01 | 0.269 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.389233e-01 | 0.268 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.389233e-01 | 0.268 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.431785e-01 | 0.265 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.431785e-01 | 0.265 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 5.431785e-01 | 0.265 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.431785e-01 | 0.265 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.431785e-01 | 0.265 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.448506e-01 | 0.264 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.448506e-01 | 0.264 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.448506e-01 | 0.264 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.448506e-01 | 0.264 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.448506e-01 | 0.264 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.448506e-01 | 0.264 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.448506e-01 | 0.264 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.448506e-01 | 0.264 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.448506e-01 | 0.264 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.448506e-01 | 0.264 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.448506e-01 | 0.264 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.448506e-01 | 0.264 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 5.453173e-01 | 0.263 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.473713e-01 | 0.262 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.482330e-01 | 0.261 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.500375e-01 | 0.260 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.538944e-01 | 0.257 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.538944e-01 | 0.257 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.538944e-01 | 0.257 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.575156e-01 | 0.254 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.575156e-01 | 0.254 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.575156e-01 | 0.254 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.575156e-01 | 0.254 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.575156e-01 | 0.254 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.627150e-01 | 0.250 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.659453e-01 | 0.247 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.659453e-01 | 0.247 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.659453e-01 | 0.247 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.659453e-01 | 0.247 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.732126e-01 | 0.242 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.732126e-01 | 0.242 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.797695e-01 | 0.237 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.797695e-01 | 0.237 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.835280e-01 | 0.234 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.852459e-01 | 0.233 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 5.852459e-01 | 0.233 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.875121e-01 | 0.231 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.875121e-01 | 0.231 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.875121e-01 | 0.231 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.875121e-01 | 0.231 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.875121e-01 | 0.231 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.875121e-01 | 0.231 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.875121e-01 | 0.231 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.875121e-01 | 0.231 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.875121e-01 | 0.231 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.875121e-01 | 0.231 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.880021e-01 | 0.231 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 5.880021e-01 | 0.231 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.920504e-01 | 0.228 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.964622e-01 | 0.224 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.966976e-01 | 0.224 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.064304e-01 | 0.217 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.093250e-01 | 0.215 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.093250e-01 | 0.215 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.093250e-01 | 0.215 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.103875e-01 | 0.214 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.116678e-01 | 0.213 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.116678e-01 | 0.213 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.116678e-01 | 0.213 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.127769e-01 | 0.213 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.127769e-01 | 0.213 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.261771e-01 | 0.203 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.261771e-01 | 0.203 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.261771e-01 | 0.203 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.261771e-01 | 0.203 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.261771e-01 | 0.203 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.261771e-01 | 0.203 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.261771e-01 | 0.203 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.261771e-01 | 0.203 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.261771e-01 | 0.203 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.261771e-01 | 0.203 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.261771e-01 | 0.203 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.261771e-01 | 0.203 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.298969e-01 | 0.201 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.298969e-01 | 0.201 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.298969e-01 | 0.201 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.298969e-01 | 0.201 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.298969e-01 | 0.201 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.298969e-01 | 0.201 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.302717e-01 | 0.200 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.367828e-01 | 0.196 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.367828e-01 | 0.196 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.367828e-01 | 0.196 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.367828e-01 | 0.196 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.367828e-01 | 0.196 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.442195e-01 | 0.191 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.454976e-01 | 0.190 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.454976e-01 | 0.190 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.460827e-01 | 0.190 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 6.486562e-01 | 0.188 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.489491e-01 | 0.188 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.497064e-01 | 0.187 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.497064e-01 | 0.187 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.497064e-01 | 0.187 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.497064e-01 | 0.187 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.574409e-01 | 0.182 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 6.583131e-01 | 0.182 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.583131e-01 | 0.182 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.583131e-01 | 0.182 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.583131e-01 | 0.182 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.583131e-01 | 0.182 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.583131e-01 | 0.182 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.606039e-01 | 0.180 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.606039e-01 | 0.180 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.606039e-01 | 0.180 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.606039e-01 | 0.180 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.606039e-01 | 0.180 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.606039e-01 | 0.180 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.606039e-01 | 0.180 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.612199e-01 | 0.180 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.612199e-01 | 0.180 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.612199e-01 | 0.180 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.612199e-01 | 0.180 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.612199e-01 | 0.180 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 6.612199e-01 | 0.180 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.612199e-01 | 0.180 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.612199e-01 | 0.180 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.612199e-01 | 0.180 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.612199e-01 | 0.180 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.622478e-01 | 0.179 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.634900e-01 | 0.178 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.687478e-01 | 0.175 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.687478e-01 | 0.175 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.687478e-01 | 0.175 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.710324e-01 | 0.173 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.716525e-01 | 0.173 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.718268e-01 | 0.173 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.722199e-01 | 0.172 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.740126e-01 | 0.171 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.784515e-01 | 0.168 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.831528e-01 | 0.165 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.831528e-01 | 0.165 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.831528e-01 | 0.165 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.831528e-01 | 0.165 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.831528e-01 | 0.165 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.831528e-01 | 0.165 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.831528e-01 | 0.165 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.831528e-01 | 0.165 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.831528e-01 | 0.165 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.831528e-01 | 0.165 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.870199e-01 | 0.163 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.870199e-01 | 0.163 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 6.870199e-01 | 0.163 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.929796e-01 | 0.159 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.929796e-01 | 0.159 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.929796e-01 | 0.159 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.929796e-01 | 0.159 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.929796e-01 | 0.159 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.929796e-01 | 0.159 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.929796e-01 | 0.159 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.929796e-01 | 0.159 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.021033e-01 | 0.154 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.032080e-01 | 0.153 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.044587e-01 | 0.152 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.044587e-01 | 0.152 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.044587e-01 | 0.152 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.044587e-01 | 0.152 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.044587e-01 | 0.152 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.044587e-01 | 0.152 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.044587e-01 | 0.152 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.044587e-01 | 0.152 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.048965e-01 | 0.152 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.092057e-01 | 0.149 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.092057e-01 | 0.149 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.092057e-01 | 0.149 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.125154e-01 | 0.147 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.156659e-01 | 0.145 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.212715e-01 | 0.142 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.212715e-01 | 0.142 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.212715e-01 | 0.142 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.212726e-01 | 0.142 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.212726e-01 | 0.142 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.217637e-01 | 0.142 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.217637e-01 | 0.142 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.217637e-01 | 0.142 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.217637e-01 | 0.142 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.217637e-01 | 0.142 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.217637e-01 | 0.142 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.217637e-01 | 0.142 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.217637e-01 | 0.142 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.217637e-01 | 0.142 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.217637e-01 | 0.142 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.217637e-01 | 0.142 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 7.217637e-01 | 0.142 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.245565e-01 | 0.140 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.245565e-01 | 0.140 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.245565e-01 | 0.140 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.245565e-01 | 0.140 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.245565e-01 | 0.140 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.245565e-01 | 0.140 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.245565e-01 | 0.140 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.261718e-01 | 0.139 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.300395e-01 | 0.137 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.372701e-01 | 0.132 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.372701e-01 | 0.132 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.377572e-01 | 0.132 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.377572e-01 | 0.132 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.404298e-01 | 0.131 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.410273e-01 | 0.130 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.432739e-01 | 0.129 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.432739e-01 | 0.129 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.432739e-01 | 0.129 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.434853e-01 | 0.129 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.434853e-01 | 0.129 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.434853e-01 | 0.129 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.434853e-01 | 0.129 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.478506e-01 | 0.126 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.478506e-01 | 0.126 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.478506e-01 | 0.126 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.478506e-01 | 0.126 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.478506e-01 | 0.126 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.478506e-01 | 0.126 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.478506e-01 | 0.126 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.478506e-01 | 0.126 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.478506e-01 | 0.126 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.478506e-01 | 0.126 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.478506e-01 | 0.126 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.478506e-01 | 0.126 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.506673e-01 | 0.125 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 7.513083e-01 | 0.124 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.519937e-01 | 0.124 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.525312e-01 | 0.123 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.525312e-01 | 0.123 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.527414e-01 | 0.123 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.531019e-01 | 0.123 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.560973e-01 | 0.121 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.564351e-01 | 0.121 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.564351e-01 | 0.121 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.565598e-01 | 0.121 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.589778e-01 | 0.120 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.612876e-01 | 0.118 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.612876e-01 | 0.118 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.612876e-01 | 0.118 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.612876e-01 | 0.118 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.641358e-01 | 0.117 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.641358e-01 | 0.117 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.644623e-01 | 0.117 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 7.647771e-01 | 0.116 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.658542e-01 | 0.116 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.670710e-01 | 0.115 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.670710e-01 | 0.115 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.670710e-01 | 0.115 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.704581e-01 | 0.113 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.714932e-01 | 0.113 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.714932e-01 | 0.113 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.714932e-01 | 0.113 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.714932e-01 | 0.113 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.714932e-01 | 0.113 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.714932e-01 | 0.113 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.714932e-01 | 0.113 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.714932e-01 | 0.113 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.714932e-01 | 0.113 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.714932e-01 | 0.113 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.780083e-01 | 0.109 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.780083e-01 | 0.109 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.780083e-01 | 0.109 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.780428e-01 | 0.109 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.780428e-01 | 0.109 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.804723e-01 | 0.108 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.804723e-01 | 0.108 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.809067e-01 | 0.107 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.809067e-01 | 0.107 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.809067e-01 | 0.107 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.836331e-01 | 0.106 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.857824e-01 | 0.105 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.868634e-01 | 0.104 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.869695e-01 | 0.104 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.922850e-01 | 0.101 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.929201e-01 | 0.101 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.929201e-01 | 0.101 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 7.929201e-01 | 0.101 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 7.929201e-01 | 0.101 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.929201e-01 | 0.101 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.929201e-01 | 0.101 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.929201e-01 | 0.101 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.929201e-01 | 0.101 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.929201e-01 | 0.101 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.929201e-01 | 0.101 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.929201e-01 | 0.101 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.929201e-01 | 0.101 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.936936e-01 | 0.100 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.936936e-01 | 0.100 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 7.940570e-01 | 0.100 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.940570e-01 | 0.100 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.972858e-01 | 0.098 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.997596e-01 | 0.097 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.997596e-01 | 0.097 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.006768e-01 | 0.097 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.059582e-01 | 0.094 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.065419e-01 | 0.093 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.073030e-01 | 0.093 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.073030e-01 | 0.093 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.083905e-01 | 0.092 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.083905e-01 | 0.092 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.083905e-01 | 0.092 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.083905e-01 | 0.092 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.083905e-01 | 0.092 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.083905e-01 | 0.092 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.083905e-01 | 0.092 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.083905e-01 | 0.092 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.083905e-01 | 0.092 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.123390e-01 | 0.090 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.123390e-01 | 0.090 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.123390e-01 | 0.090 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.123390e-01 | 0.090 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.123390e-01 | 0.090 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.123390e-01 | 0.090 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.123390e-01 | 0.090 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.123390e-01 | 0.090 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.123390e-01 | 0.090 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.123390e-01 | 0.090 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.123390e-01 | 0.090 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.169226e-01 | 0.088 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.183824e-01 | 0.087 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.183824e-01 | 0.087 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.198115e-01 | 0.086 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.209983e-01 | 0.086 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.221466e-01 | 0.085 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.221466e-01 | 0.085 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.221466e-01 | 0.085 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.221466e-01 | 0.085 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.236509e-01 | 0.084 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.242081e-01 | 0.084 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.243096e-01 | 0.084 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.276129e-01 | 0.082 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.296006e-01 | 0.081 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.296006e-01 | 0.081 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.299380e-01 | 0.081 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.299380e-01 | 0.081 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.299380e-01 | 0.081 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.299380e-01 | 0.081 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.299380e-01 | 0.081 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.299380e-01 | 0.081 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.299380e-01 | 0.081 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.299380e-01 | 0.081 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.299380e-01 | 0.081 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.299380e-01 | 0.081 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.299380e-01 | 0.081 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.326997e-01 | 0.080 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.350018e-01 | 0.078 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.350018e-01 | 0.078 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.388304e-01 | 0.076 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.394661e-01 | 0.076 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.402186e-01 | 0.076 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.402186e-01 | 0.076 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.402186e-01 | 0.076 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.402186e-01 | 0.076 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.402186e-01 | 0.076 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.403641e-01 | 0.076 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.406756e-01 | 0.075 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.422285e-01 | 0.075 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.434790e-01 | 0.074 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.458874e-01 | 0.073 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.458874e-01 | 0.073 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.458874e-01 | 0.073 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.458874e-01 | 0.073 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.458874e-01 | 0.073 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.458874e-01 | 0.073 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.458874e-01 | 0.073 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.458874e-01 | 0.073 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.458874e-01 | 0.073 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.458874e-01 | 0.073 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.458874e-01 | 0.073 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.458874e-01 | 0.073 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.470240e-01 | 0.072 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.470240e-01 | 0.072 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.470240e-01 | 0.072 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.493370e-01 | 0.071 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.498956e-01 | 0.071 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.502593e-01 | 0.070 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.502593e-01 | 0.070 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.582378e-01 | 0.066 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 8.582378e-01 | 0.066 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.582378e-01 | 0.066 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.582378e-01 | 0.066 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.597456e-01 | 0.066 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.603419e-01 | 0.065 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.603419e-01 | 0.065 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.603419e-01 | 0.065 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.603419e-01 | 0.065 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.603419e-01 | 0.065 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.603419e-01 | 0.065 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.603419e-01 | 0.065 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.603419e-01 | 0.065 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.603419e-01 | 0.065 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.603419e-01 | 0.065 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.603419e-01 | 0.065 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 8.625573e-01 | 0.064 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.644074e-01 | 0.063 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.686947e-01 | 0.061 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.686947e-01 | 0.061 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.686947e-01 | 0.061 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.686947e-01 | 0.061 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.686947e-01 | 0.061 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.734414e-01 | 0.059 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.734414e-01 | 0.059 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.734414e-01 | 0.059 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.734414e-01 | 0.059 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.734414e-01 | 0.059 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.734414e-01 | 0.059 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.734414e-01 | 0.059 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.734414e-01 | 0.059 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.734414e-01 | 0.059 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.734414e-01 | 0.059 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.784381e-01 | 0.056 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.784381e-01 | 0.056 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.806248e-01 | 0.055 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.811326e-01 | 0.055 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.851066e-01 | 0.053 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.853130e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.853130e-01 | 0.053 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.853130e-01 | 0.053 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.853130e-01 | 0.053 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.853130e-01 | 0.053 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.853130e-01 | 0.053 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.853130e-01 | 0.053 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.853130e-01 | 0.053 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.853130e-01 | 0.053 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.853130e-01 | 0.053 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.853130e-01 | 0.053 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 8.870765e-01 | 0.052 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.875097e-01 | 0.052 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.875097e-01 | 0.052 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.926029e-01 | 0.049 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.947227e-01 | 0.048 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.959498e-01 | 0.048 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.960716e-01 | 0.048 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.960716e-01 | 0.048 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.960716e-01 | 0.048 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.960716e-01 | 0.048 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.960716e-01 | 0.048 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.988573e-01 | 0.046 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.991521e-01 | 0.046 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.996573e-01 | 0.046 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.037971e-01 | 0.044 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.046624e-01 | 0.044 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.058215e-01 | 0.043 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.058215e-01 | 0.043 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.058215e-01 | 0.043 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.058215e-01 | 0.043 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.058215e-01 | 0.043 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.058215e-01 | 0.043 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.062911e-01 | 0.043 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.069281e-01 | 0.042 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.107207e-01 | 0.041 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.107207e-01 | 0.041 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 9.110885e-01 | 0.040 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 9.110885e-01 | 0.040 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.110885e-01 | 0.040 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.125468e-01 | 0.040 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.125468e-01 | 0.040 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.135129e-01 | 0.039 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.144294e-01 | 0.039 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.146573e-01 | 0.039 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.146573e-01 | 0.039 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.146573e-01 | 0.039 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.146573e-01 | 0.039 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.146573e-01 | 0.039 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.146573e-01 | 0.039 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.146573e-01 | 0.039 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.178591e-01 | 0.037 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.178591e-01 | 0.037 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.226645e-01 | 0.035 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.226645e-01 | 0.035 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.241424e-01 | 0.034 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.241424e-01 | 0.034 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.246313e-01 | 0.034 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.290283e-01 | 0.032 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.299210e-01 | 0.032 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.299210e-01 | 0.032 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.299210e-01 | 0.032 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.299210e-01 | 0.032 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.299704e-01 | 0.032 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.353730e-01 | 0.029 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.363388e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.364969e-01 | 0.028 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.364969e-01 | 0.028 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.364969e-01 | 0.028 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.364969e-01 | 0.028 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.364969e-01 | 0.028 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.364969e-01 | 0.028 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.364969e-01 | 0.028 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.373162e-01 | 0.028 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.373162e-01 | 0.028 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.403787e-01 | 0.027 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.403787e-01 | 0.027 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.424561e-01 | 0.026 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.424561e-01 | 0.026 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.424561e-01 | 0.026 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.424561e-01 | 0.026 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.424561e-01 | 0.026 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.437682e-01 | 0.025 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.441516e-01 | 0.025 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.441516e-01 | 0.025 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.441516e-01 | 0.025 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.450145e-01 | 0.025 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.465903e-01 | 0.024 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.478565e-01 | 0.023 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.478565e-01 | 0.023 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.478565e-01 | 0.023 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.509604e-01 | 0.022 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.527503e-01 | 0.021 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.527503e-01 | 0.021 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.527503e-01 | 0.021 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.532761e-01 | 0.021 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.532761e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.532761e-01 | 0.021 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.537687e-01 | 0.021 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.540986e-01 | 0.020 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.560700e-01 | 0.020 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.569481e-01 | 0.019 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.569481e-01 | 0.019 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.569481e-01 | 0.019 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.570509e-01 | 0.019 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.571851e-01 | 0.019 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.571851e-01 | 0.019 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.571851e-01 | 0.019 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.571851e-01 | 0.019 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.571851e-01 | 0.019 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.595180e-01 | 0.018 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.600368e-01 | 0.018 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.600368e-01 | 0.018 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.603496e-01 | 0.018 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.603502e-01 | 0.018 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.612038e-01 | 0.017 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.612038e-01 | 0.017 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.612038e-01 | 0.017 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.612038e-01 | 0.017 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.612038e-01 | 0.017 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.612038e-01 | 0.017 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.628629e-01 | 0.016 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.634797e-01 | 0.016 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.648456e-01 | 0.016 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.648456e-01 | 0.016 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.681457e-01 | 0.014 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.681457e-01 | 0.014 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.681457e-01 | 0.014 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.681457e-01 | 0.014 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.690531e-01 | 0.014 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.693486e-01 | 0.014 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.702533e-01 | 0.013 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.711362e-01 | 0.013 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.715230e-01 | 0.013 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.723907e-01 | 0.012 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.731644e-01 | 0.012 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.751429e-01 | 0.011 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.759044e-01 | 0.011 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.763018e-01 | 0.010 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.778431e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.779626e-01 | 0.010 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.782925e-01 | 0.010 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.785270e-01 | 0.009 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.785270e-01 | 0.009 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.795689e-01 | 0.009 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.800858e-01 | 0.009 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.805433e-01 | 0.009 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.805433e-01 | 0.009 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.808411e-01 | 0.008 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.823705e-01 | 0.008 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.823705e-01 | 0.008 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.823705e-01 | 0.008 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.824527e-01 | 0.008 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.849448e-01 | 0.007 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.854797e-01 | 0.006 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.855264e-01 | 0.006 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.855264e-01 | 0.006 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.862649e-01 | 0.006 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.866393e-01 | 0.006 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.866645e-01 | 0.006 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.868858e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.868858e-01 | 0.006 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.868858e-01 | 0.006 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.868858e-01 | 0.006 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.880569e-01 | 0.005 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.881176e-01 | 0.005 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.896299e-01 | 0.005 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.902452e-01 | 0.004 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.905301e-01 | 0.004 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.911617e-01 | 0.004 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.912645e-01 | 0.004 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.913106e-01 | 0.004 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.914216e-01 | 0.004 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.919920e-01 | 0.003 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.925636e-01 | 0.003 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.931154e-01 | 0.003 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.931154e-01 | 0.003 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.940440e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.941178e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.943614e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.944853e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.946037e-01 | 0.002 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.955703e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.960114e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.960114e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.960212e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.960454e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.963270e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.963546e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.966361e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.967057e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.969411e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.970154e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.970154e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.975502e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.980313e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.982451e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.982878e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.984256e-01 | 0.001 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.986455e-01 | 0.001 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.986455e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.987729e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.987729e-01 | 0.001 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.988442e-01 | 0.001 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.988791e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.993421e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.993647e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.993820e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.993855e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.993855e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.994433e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.994855e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.995205e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.995366e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.995862e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.995862e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.996035e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.996251e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.996399e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997200e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.997831e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998176e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998407e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998461e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999272e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999432e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999468e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999540e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999615e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999662e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999673e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999741e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999787e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999815e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999840e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999935e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999947e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999964e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999964e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999981e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999983e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999989e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999991e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999998e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |